TW201107479A - Fabrication method of microbial cell treated material - Google Patents

Fabrication method of microbial cell treated material Download PDF

Info

Publication number
TW201107479A
TW201107479A TW099123033A TW99123033A TW201107479A TW 201107479 A TW201107479 A TW 201107479A TW 099123033 A TW099123033 A TW 099123033A TW 99123033 A TW99123033 A TW 99123033A TW 201107479 A TW201107479 A TW 201107479A
Authority
TW
Taiwan
Prior art keywords
acrylamide
acid
producing
meth
solution
Prior art date
Application number
TW099123033A
Other languages
Chinese (zh)
Inventor
Teruo Arii
Toshikazu Aikawa
Kiyoshi Ito
Yoshikazu Uehara
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Publication of TW201107479A publication Critical patent/TW201107479A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/52Amides or imides
    • C08F20/54Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F20/56Acrylamide; Methacrylamide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/01Hydro-lyases (4.2.1)
    • C12Y402/01084Nitrile hydratase (4.2.1.84)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

A microbial cell treated material containing an ionized nitrile-hydratase is fabricated by breaking a microbial cell which generates the nitrile-hydratase through homogenizer, and then treating the broken microbial cell by acid. Using the microbial cell treated material as a catalyst to fabricated amide, such as (methyl) acrylamide. According to the present invention, high quality amide, such as (methyl) acrylamide, can be fabricated without purification when fabricating the useful (methyl) acrylamide in manufacturing industry by catalyzed reaction of nitrile-hydratase. Besides, an efficient fabricating method of the beneficial catalyst is also provided.

Description

201107479; 六、發明說明: 【發明所屬之技術領域】 本發明是有關於一種包含了藉由菌體而游離之腈水合 酶(nitrile-hydratase)的菌體處理物的製造方法、利用此 菌體處理物的(曱基)丙烯醯胺的製造方法、及使用此(甲基) 丙烯醯胺的聚合物的製造方法。 【先前技術】 對於將腈化合物的腈基進行水合而轉變成酿胺基,而 製造相對應的醯胺化合物的技術,先前以來已知有:在酸 或驗存在下、或銅觸媒存在下對腈化合物進行加熱處理的 化學性方法。 另外,近年來,發現作為具有將腈基進行水合 (hydration)而轉變為醯胺基的腈水合活性的酶的腈水合 酶,並一直對使用含有此酶的微生物菌體等,以由腈化合 物製造對應的醯胺化合物的方法進行研究。此製造方法與 先前的化學性方法相比,已知有自腈化合物向對應的酸胺 化合物的轉化率及選擇率較高等的優點,並由於是極為 易的製程組成,而認為是有力的工業上的的製 如丄 照專利文獻1〜5)。 参 根據該些先前技術文獻,記載有:不僅可使用菌 =可使贿由超音波處理特菌體破碎_體破碎物、’ ,體破碎後製備的粗酶(enide enzyme)、部分 (punfied enzyme)或純化酶之類的菌體處理物, 姆 丙烯腈轉變為(f基)丙烯醯胺。在該些切技街文^中基) 201107479 揭示有菌體處理物可與菌體同等地製造(甲基)丙稀醯胺, 但為了使用菌體處理物製造高品質的(甲基)丙烯賴,仍 有改善的餘地。 拼斤另外,使用菌體、菌體處理物等進行反應時,若蛋白 質等雜質殘存在此8體、_處理物中,則存在以下情況: 例如(甲基)丙稀酿胺容易發泡等、對所製造的(曱基)丙歸酿 胺的品質造成不良影響。 一作為此種雜質得到降低的、使用微生物觸媒的、 丙稀醯胺的方法,已知有:將由微生物菌 ,2^^ 土丙烯醯胺藉由活性炭進行純化的方法(例 如多戸、?、專利文獻6、7 ),或夢由老^卢 如參照專利文獻8)等^由屯^方法(例 化步驟中別 疋上述純化方法中,在其純 驟的製程^ 備’因而期制發—種無需純化步 人利㈣由丙馳水溶㈣行清洗的微生物觸蛘 胺’再進行薄膜過遽而製造的 勿= 了南保存性(例如參照專利文獻9)。 貝現 f』:質的丙稀醯胺水溶液作為原料而 _胺(例如參照專利文獻10)。 專利文獻2 專利文獻3 專利文獻4 專利文獻5 1 .日本專利特開平09-275978號公報 曰本專利特開平11-253168號公報 曰本專利特開平11-089575號公報 曰本專利特開2002-281994號公報 曰本專利特公昭59-037951號公報 Μ 5 201107479 曰本專利特開2001-270857號公報 曰本專利特公平02-009022號公報 曰本專利特開2004-298155號公報 曰本專利特開2002-281994號公報 :曰本專利特開2007-277563號公報 專利文獻6 專利文獻7 專利文獻8 專利文獻9 專利文獻10 【發明内容】 本發明的課題是提供一種具有能製造高品質的(甲基) 丙烯醯胺的腈水合酶活性的菌體處理物的製造方法、使用 此菌體處理物的(曱基)丙烯醯胺的製造方法、及使用此(甲 基)丙烯醯胺的(曱基)丙烯醯胺系聚合物的製造方法。 本發明者等人為了解決上述課題㈣(?基化稀酿胺 及其聚合物的製造方法進行了反魏意研究。結果發現, 若藉由均質II (hGnu>genize〇等將產生腈水合酶的微生物 的涵體破碎,舰對已破碎㈣體騎處理,將不溶 去產物進行驗處理等,使用所得㈣體處理物製造 (曱基)丙_胺,浙便包含蛋白質錢乎見 軌即可製造出能製造高品質聚合物心質優 /、的(曱基)丙烯醯胺;從而完成了本發明。 即’本發明如以下所述。 (Ό-種包含游離腈水合酶的菌體處理物 法’ ”基於..製作產生腈水合酶的 用酸對此破碎物進行處理後將不 的产 理的破碎物進行鹼處理。 方接考對用酸處 201107479 (r) 一種包含游離腈水合酶的菌體處理物的譽造方 法,其包括: 衣过 (1) 製作產生腈水合酶的微生物的菌體破碎物的步雜, (2) 對此菌體破碎物進行酸處理的步驟, , (3) 將上述步驟⑺的酸處理時所生成的不溶物除 去的步驟,及 (4)對經過上述步驟(3)的菌體破碎物進行鹼處理 中所使用的酸為弱酸。 (II)如項⑴< (Ρ)所述的菌體處理物的製造方 法,其中上述(I)中所使用的酸、即上述(1,)的步驟⑺ (III)如項(II)所述的菌體處理物的製造方法,其 中上述弱酸為選自丙烯酸、乙酸 、及磷酸中的反少1鍤。[Technical Field] The present invention relates to a method for producing a bacterial body treated product comprising a nitrile hydratase free from a bacterial cell, and using the bacterial cell A method for producing a (mercapto) acrylamide of a treated material, and a method for producing a polymer using the (meth) acrylamide. [Prior Art] A technique for producing a corresponding guanamine compound by hydrating a nitrile group of a nitrile compound to form a corresponding amine group, which has been previously known in the presence of an acid or a test, or in the presence of a copper catalyst A chemical method of heat treatment of a nitrile compound. In addition, in recent years, it has been found that a nitrile hydratase which is an enzyme having a nitrile hydration activity which is converted into a mercapto group by hydration of a nitrile group, has been used for a nitrile compound by using a microbial cell containing the enzyme or the like. A method of producing a corresponding guanamine compound was studied. Compared with the prior chemical methods, this manufacturing method is known to have advantages such as a high conversion rate and a high selectivity from a nitrile compound to a corresponding acid amine compound, and is considered to be a powerful industrial because it is an extremely easy process composition. The above system is as described in Patent Documents 1 to 5). According to the prior art documents, it is described that not only bacteria can be used, but also bribes can be processed by ultrasonic treatment, and the body is broken, the body is broken, and the enide enzyme and the part (punfied enzyme) are prepared after the body is broken. Or a bacterial treatment such as a purified enzyme, and the acrylonitrile is converted into (f-based) acrylamide. In the above-mentioned cutting technique, the company has disclosed that (7) acrylamide can be produced in the same manner as the bacterial cells, but high-quality (meth) propylene is produced in order to use the bacterial treatment. Lai, there is still room for improvement. In addition, when a reaction such as a protein or a bacterium is left in the case of the reaction of the bacteria, the bacterium, or the like, the following conditions may occur: For example, (meth) acrylamide is easy to foam, etc. It adversely affects the quality of the manufactured (indenyl) glycerol. A method of purifying acrylamide using a microbial catalyst which is reduced as such an impurity, and a method of purifying a microbial bacterium, acrylamide, by activated carbon (for example, polyhydrazine, ? , Patent Document 6, 7), or Dreams by Lao Lu, such as the reference to the patent document 8), etc. by the method of 屯^ (in the crystallization step, in the above-mentioned purification method, in the pure process of the process)发 种 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需 无需The acrylamide aqueous solution is used as a raw material and the amine is used as a raw material (for example, refer to Patent Document 10). Patent Document 2 Patent Document 3 Patent Document 4 Patent Document 5 1 Japanese Patent Laid-Open No. Hei 09-275978, Japanese Patent Laid-Open No. Hei 11-253168 Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. 02-009022 JP-A-2004-298155, JP-A-2002-199495, JP-A-2007-277563, JP-A-2006-277563, JP-A No. JP-A----- A problem is to provide a method for producing a cell treated product having a nitrile hydratase activity capable of producing high-quality (meth) acrylamide, and a method for producing (mercapto) acrylamide using the cell treated product, and A method for producing a (mercapto) acrylamide-based polymer using the (meth) acrylamide. The present inventors have solved the above problems (4) (methods for the production of a base-based thin amine and a polymer thereof). Anti-Weiyi study. It was found that if the body of the microorganism producing nitrile hydratase was broken by homogenization II (hGnu>genize〇, the ship pair was broken (four) body riding treatment, the insoluble product was inspected, etc., used The obtained (four) body treatment product produces (mercapto) propylene-amine, and the product contains the protein money to produce a high-quality polymer core-quality (meth) acrylamide; thus completing the hair That is, the present invention is as follows. (Ό-species method for the treatment of cells containing free nitrile hydratase] is based on: production of nitrile hydratase-containing acid to treat the broken product The crushed material is subjected to alkali treatment. The method for the use of acid at 201107479 (r) is a well-known method for treating a bacterial body containing a free nitrile hydratase, which comprises: coating (1) producing a microorganism producing nitrile hydratase a step of the bacterial body disrupted product, (2) a step of acid-treating the bacterial cell disrupted material, (3) a step of removing the insoluble matter formed during the acid treatment of the above step (7), and (4) a pair of passing The acid used in the alkali treatment of the cell disrupted material in the above step (3) is a weak acid. (II) The method for producing a bacterial body treated product according to the above (1), wherein the acid used in the above (I), that is, the step (7) (III) of the above (1), is as defined in the item (II). The method for producing a bacterial cell treated product, wherein the weak acid is an antimony selected from the group consisting of acrylic acid, acetic acid, and phosphoric acid.

.1+ ^ / 王依:,冉利用樹脂或 的至—種進行後處理。 中上述助濾劑為矽藻土。 +、#、H (1,所迷的菌體處理物的製造方法 (VI)如項(V)所述的菌 中上述石夕藻土為Celite。 (VII)如項(IV)所述的 體處理物的製造方法,其 中上述樹脂為離子交換樹月旨。 (VIII)如項(I’)、及 义的囷體處理物的製造方法,其 脂。 及(1)至(VII)中任一項所述 201107479 的菌體處理物的製造方法,其中產生腈水合酶的微生物為 在任思的伯主中兩度表現由此微生物選殖(cl〇njng )的猜 水合S#基因的形質轉換體(transf〇rmat);及利用重組dna 技術使此腈水合酶的構成胺基酸的1個或2個以上藉由其 他胺基酸置換、缺失(deletion)、削除或插入,而表現耐 醯胺化合物性或耐腈化合物性、时溫度性進一步提昇的變 異型腈水合酶的形質轉換體。 (IX) 如項(Γ)、及(I)至(VIII)中任一項所述的 製造方法,其中產生腈水合酶的微生物為屬於假諾卡氏菌 (Pseudonocardia)屬的微生物。 (X) 一種(甲基)丙烯醯胺的製造方法,其是利用藉由 如項(Γ)及(I)〜(IX)中任一項所述的製造方法而得 的菌體處理物,由(甲基)丙烯腈製造(曱基)丙烯醯胺。 (XI) —種(曱基)丙烯醯胺,其由如項(X)所述的製 造方法而得。 (XII) —種由如項(X)所述的製造方法而得的(甲基) 丙烯醯胺水溶液,其在每1 L的40 wt% (重量百分比)〜 80 wt%的丙烯醯胺或1 〇 wt%〜4〇 wt%的曱基丙烯醯胺、及 水的溶液中包含0.1 mg〜50 mg的蛋白質。 (XIII) —種(甲基)丙烯醯胺系聚合物的製造方法,其 是使用如項(XI)所述的(甲基)丙烯醯胺、或如項(XII) 所述的(甲基)丙烯醯胺水溶液而製造(甲基)丙烯醯胺系聚 合物。 發明的效果 根據本發明,可無須純化即可製造出能製造高品質的 201107479」 聚合物的品質優異的丙稀酿胺。 ▲為讓本發明之上述和其他目的、特徵和優點能更明顯 易懂,下文特舉較佳實施例,並配合所關式,作詳細 明如下。 、β 【實施方式】 本發明中可用的產生腈水合酶的微生物可列舉屬於以 下屬的被生物荨·奴卡氏菌(Nocar(jia)屬、棒狀桿菌 (Corynebacterium)屬、桿狀菌(Badllus)屬、嗜熱性桿 狀菌屬、偽單胞菌(Pseudomonas)屬、微球菌(Micr〇c〇ccus ) 屬 '以紫紅色(rhodochrous )種為代表的紅球菌 (Rhodococcus)屬、不動桿菌(Acinet〇bacter)屬、黃色 桿菌(Xanthobacter)屬、鏈黴菌(Strept〇myces)屬;;根 瘤菌(Rhizobiimi)屬、克雷白氏菌(Klebsiella)屬、腸 桿菌(Enterobacter)屬、伊文氏桿菌(Erwinia)屬、產氣 單胞菌(Aeromonas)屬、檸檬酸桿菌(citr〇bacter)屬、 無色桿菌(Achromobacter)屬、農桿菌(Agr〇bacterium) 屬或以嗜熱(thermophila )種為代表的假諾卡氏菌 (Pseudonocardia)屬、無芽孢桿菌(Bacteridium)屬、短 桿菌(Brevibacterium)屬。另外亦可列舉:在任意的宿主 中咼度表現由該些微生物選殖的腈水合酶基因的形質轉換 體;及利用重組DNA技術使此腈水合酶的構成胺基酸的1 個或2個以上藉由其他胺基酸置換、缺失、削除或插入, 而表現耐醯胺化合物性或耐腈化合物性、耐溫度性進一步 提昇的變異型腈水合酶的形質轉換體等。 201107479 另外,此處所謂的任意的宿主(host),如後述的實例 般,可列舉大腸菌(Escherichia coli)作為代表例,但並不 ,別限定於大腸菌,亦可包括枯草桿菌(Bacmussubtilis) 等桿狀菌屬菌,酵母或放線菌等其他微生物菌株。如上述 般的菌的例子可列舉:MT_10822 (此菌株是在1996年2 月7曰以寄存編號pERM BP_5785,基於與專利程序上微 生物寄存的國際承認相關的布達佩斯條約而寄存在茨城縣 築波市東1T目1番3號的通商產業省工業技術院生命工 學工業技術研究所(現茨城縣築波市東築波中心 中央第6獨立行政法人產業技術綜合研究所專利生物 寄存中心。.1+ ^ / Wang Yi:, 冉Use resin or the same type for post-treatment. The above filter aid is diatomaceous earth. +, #, H (1) The method for producing a bacterial cell treated product (VI) The fungus described in the item (V) is Celite. (VII) The compound according to the item (IV) The method for producing a body treated product, wherein the resin is an ion exchange tree. (VIII) The method for producing a carcass treated product according to the item (I'), and the like, wherein the resin is (1) to (VII) The method for producing a bacterial cell treated product according to any one of the above-mentioned 201107479, wherein the microorganism producing a nitrile hydratase is a form of a water-sucking S# gene which is twice expressed by the microorganism in the host of the Rensi (cl〇njng). a transformant (transf〇rmat); and one or more of the constituent amino acids of the nitrile hydratase are replaced, deleted, removed, or inserted by other amino acids by a recombinant DNA technique. A shape-transformer of a variant nitrile hydratase which is further improved in a guanamine-containing compound or a nitrile-resistant compound and a temperature-increasing property. (IX) The method according to any one of (1), (1) to (VIII) The production method, wherein the microorganism producing nitrile hydratase is a microorganism belonging to the genus Pseudonocardia. And a method for producing a (meth) acrylamide, which is obtained by using the method according to any one of the items (I) and (I) to (IX), (Methyl) acrylonitrile (mercapto) acrylamide. (XI) - (mercapto) acrylamide obtained by the production method according to item (X). (XII) - (X) an aqueous solution of (meth)acrylamide obtained by the production method described in which it is 40 wt% (weight%) to 80 wt% of acrylamide or 1 wt% to 4 wt% per 1 L of L The solution of % mercapto acrylamide and water contains 0.1 mg to 50 mg of protein. (XIII) A method for producing a (meth) acrylamide polymer, which is used in the item (XI) The (meth) acrylamide or the (meth) acrylamide aqueous solution described in the above (XII) is used to produce a (meth) acrylamide polymer. Advantageous Effects of Invention According to the present invention, purification is not required The above-mentioned and other objects, features and advantages of the present invention can be produced by producing a high-quality 201107479" polymer. The following is a detailed description of the preferred embodiment, and the following is a detailed description of the following: [beta] [Embodiment] The nitrile hydratase-producing microorganism which can be used in the present invention may be exemplified by the following genus. Nocardia, Corynebacterium, Badllus, Thermophilic genus, Pseudomonas, Micr〇c〇 Ccus ) is a genus of Rhodococcus, Acinet〇bacter, Xanthobacter, and Strept〇myces represented by rhodochrous species; Rhizobium ( Rhizobiimi), Klebsiella, Enterobacter, Erwinia, Aeromonas, Citrobacter, colorless A genus of Achromobacter, Agr〇bacterium or Pseudonocardia, Bacteridium, and Brevibacterium represented by thermophila. Further, a shape conversion body of a nitrile hydratase gene which is selected from the microorganisms in any host; and one or two amino acid constituting the nitrile hydratase by recombinant DNA technology may be mentioned. In the above, a shape-converting substance of a variant nitrile hydratase exhibiting resistance to guanamine compound, nitrile-resistant compound, and temperature resistance is further improved by substitution, deletion, removal or insertion of other amino acids. 201107479 In addition, as an example of the example described below, Escherichia coli is used as a representative example, but it is not limited to coliforms, and may include rods such as Bacmus subtilis. Other microbial strains such as bacteria, yeast or actinomycetes. An example of the above-mentioned bacteria is: MT_10822 (This strain was deposited in the city of Tsukuba, Ibaraki Prefecture on February 7, 1996 under the registration number pERM BP_5785, based on the Budapest Treaty relating to international recognition of microbiological deposits in patent procedures. 1T, 1st, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd

該些微生物中,就具有高活性、高穩定性的腈水合酶的 方面而言,較佳為屬於假諾卡氏菌(Pseud〇n〇cardia)屬的 微生物、及在任意的宿主中高度表現由此微生物選殖的腈水 合酶基因的形質轉換體、及表現變異型腈水合酶的形質 體形質轉換體。另外,上述形質轉換體就進一步提^腈水人 酶的穩定性、每個菌體的活性更高的方面而言,較佳D 另外’在微生物内可高度表現腈水合酶的紫紅色紅球 菌(Rhodococcus rhodochrous) J-1、在任意的宿主中山产 表現由此微生物選殖的腈水合酶基因的形質轉換體二 較佳。 、、叫樣 上述產生腈水合酶的微生物的菌體可藉由分子生物 學、生物工程、基因工程的領域中公知的一般方法77而製備。 例如可藉由以下方式而製備:在LB培養基、養美等 201107479 通常的液體培養基中,將微生物植菌後,在適當的培養溫 度(通常為20°C〜耽,在嗜熱菌的情況下 以上 使微生物生育。 本發明中,將上述產生腈水合_微生物的菌體破 碎’而製作菌體破碎物(步驟(丨))。 所破碎的微生物的菌體的形態只要包含產生猜水合酶 ί微生物的菌體,則並無特別限制,例如可列舉:包含此 菌體的培養液本身、將此培養液離心分離而分離、回收的 集菌體、將此集菌體再用生理鹽水等清洗而得的菌體等。 將上述菌體破石卞的裝置只要能破碎菌體 限制,例如可列舉:超音波破碎機、法式壓壺咖^ 震動機(以_ .加)、均質器、珠磨機 L )、來結破碎機(cool mill)等磨碎裝置等。 能廉價地擴大規模(SCaI,)的方面而言, 二二罟:态。另外’所謂均質器,是指利用螺紋或油壓 ==活塞(PiSt〇n)進行送液的柱塞(_) 式间[泵的出口的均質閥(h〇m〇genizing valve )的間隙, 間產生剪斷、猛撞、空洞(cavitati°n) 司、IZUMIFOO]^。此均質器在三和機械股份有限公 MIF00D MAC_ERY股份有限公司等 將囷體破碎時的溫度並無 贼以下,更佳為代以上坑以下。^為〇C以上 另外,將菌體破碎時的Ή值 π值為4以上1〇以下,更佳為阳值為為 m. 11 201107479 使用均貝盗將菌體破碎時的屢力只 屢力,則__彳,_職Pa以上3== 下,更佳為物a以上】〇嶋以下。〇〇驗以 :以'如上所述的方式製作菌體破碎物後、即 ^^"士後,用酸對此菌體破碎物進行處理(步 驟())。错由此酸處理,可使對(歹 不良影ί的 箄強η!損及本發明的效果,則並無特別限制,硫酸 :方面夂二 使用,但就酸處理時酶活性的降低較少 的方面而§,較佳為弱酸。 - 上述弱酸可列舉丙婦酸、乙酸、鱗酸等。該些弱酸卜 由於乙酸及魏麟劇毒物,因此容祕作。" 以下用=體破碎物進行處理時的阳值較佳為4以上6 以下,更‘為pH值為4.5以上5.5以下。 的酸^菌體破碎物進行處理時,為使菌體整體 的pH值均勻,較理想的是緩慢添加酸。 另外,在上述酸處理之前, 對菌體破碎物進行熱處理。若進行熱處理 碎物進行處理時,可更容易地使所產生的不== 破碎物的熱處理溫度難為价以上机以/更 50C以上60。〇以下。菌體破碎物的熱處理時間較 分 !里以上⑽分鐘以下,更佳為5分鐘以上6g分鐘町。 經進订上述酸處理、即經過上述步驟⑺的菌體破碎 201107479: 酸處理而析出的不溶物除去(步驟⑴)。推測此 有若包含在(甲基)丙騎胺中則會對(甲基)丙 成影響的雜質、及具有容易使(甲基)丙 孤㈣泡的發泡性的來自菌體或培養液的物質。 在以ί二在(甲基)_Si胺的發泡性較大時’例如會存 例f聚(甲基娜胺等時,為了除二: 不良影響的物質等,有時進杆腺务〜/對後、·貝反應w成 丙_胺中的處理。此時^將甲=丙等说氣體吹入至(甲基) 則發泡明顯,據此‘^ 胺的發泡性高 而導致後續的操作變;應裝置内溢出: 隨胺的操作中,(曱基)丙烯π:基)丙稀 =物崎作方法例如可列;=等。 處理物的除去操作可在進行酸 , 丁仁在酉夂處理後,較佳Λ 1 ,㈣ 小時以下的期間,更佳為3小時以上^^小時以上72 始。進行除去2以下的期間開 限制,較佳為進行72 , 士要了除去不洛物,則並無特別 時以下的時間。 知以下的時間,更佳為進行48小 進行=:驟物:=後:即經過上述步驟⑴後, 酸所引起的不溶物進_步=出進仃此驗處理,而可抑制因 13 m. 201107479 此驗處理時所使用的驗只要不損及本發明的效果,則 並無特別限制,就廉價的驗的方面而言,較佳為氫氧化鈉。 上述鹼處理時的pH值較佳為PH值為6以上8以下。 在此鹼處理即上述步驟(4)後,可進一步利用微濾膜 (MF 膜(microfiltration membrane))及/或超濾膜(UF 膜 (ultrafiltration membrane ))進行過渡。 上述MF過濾膜的孔徑較佳為〇〗μπ1以上2 μιη以 下’更佳為0·1 μιη以上〇_45 μιη以下,尤佳為0.1 μιη以上 0.2 μπι 以下。 另外,上述微濾膜(MF膜)、及超濾膜(UF膜)膜 的材料較佳為無腈水合酶吸附的材料,具體而言,較佳為 聚偏二氟乙烯、聚醚砜、聚砜、聚丙稀腈。 method)等。 另外’使用上述微濾膜(MF膜)、及超濾膜(UF膜) 的過濾法並無特別限制,例如可列舉:垂直流過濾法(dead end filtration method)、掃流過濾法(cr〇ss_fl〇w flltmti〇n ,而有更可靠地除去上述不溶物、 错由利用此微渡膜(MF膜)、超濾膜(UF膜)的處Among these microorganisms, in terms of a highly active and highly stable nitrile hydratase, it is preferably a microorganism belonging to the genus Pseud〇n〇cardia and highly expressed in any host. The shape transformant of the nitrile hydratase gene selected by the microorganism, and the morphological transformant of the variant nitrile hydratase. In addition, the above-mentioned shape transforming body further improves the stability of the nitrile hydroenzyme and the activity of each of the cells is higher, and preferably D additionally 'the Rhodococcus rhodochrous which can highly express the nitrile hydratase in the microorganism. (Rhodococcus rhodochrous) J-1. The shape-converting body 2 of the nitrile hydratase gene which is produced by the microorganism in any of the hosts is preferred. The cells of the above-described nitrile hydratase-producing microorganism can be prepared by a general method 77 known in the fields of molecular biology, bioengineering, and genetic engineering. For example, it can be prepared by culturing the microorganisms in a usual liquid medium of LB medium, Yangmei et al 201107479, at a suitable culture temperature (usually 20 ° C ~ 耽, in the case of thermophiles) In the present invention, the microbial cell produced by the above-described nitrile hydration-microorganism is broken up to produce a bacterial cell disrupted product (step (丨)). The form of the microbial cell of the broken microorganism includes the production of a hydrating enzyme. The microbial cells are not particularly limited, and examples thereof include a culture solution containing the cells, a collection and collection of the culture solution by centrifugation, and the collection of the cells by physiological saline. The obtained bacteria, etc. The apparatus for breaking the stone into the above-mentioned cells can be broken as long as it can break the bacteria, for example, an ultrasonic breaker, a French pressure pot, a vibration machine (with _. plus), a homogenizer, and beads. Grinding machine L), a crushing device such as a cool mill, and the like. In terms of being able to expand the scale (SCaI,) at a low cost, it is a state of two. In addition, the so-called homogenizer refers to the gap between the plungers (_) of the pump (the outlet of the pump, the h〇m〇genizing valve) by the screw or the hydraulic pressure == piston (PiSt〇n). There are shears, slams, holes (cavitati°n), IZUMIFOO]^. This homogenizer is not less than a thief when the carcass is broken, such as MIF00D MAC_ERY Co., Ltd., etc., and it is better to be below the pit. ^ is 〇C or more, when the cell is broken, the π value of π is 4 or more and 1 〇 or less, and more preferably, the positive value is m. 11 201107479 The use of the scallops to break the bacteria is only repeated. , then __ 彳, _ job Pa above 3 ==, better for the object a above 〇嶋 〇嶋 below. After the preparation of the bacterial cell disrupted material as described above, that is, ^^", the bacterial cell disrupted material is treated with acid (step ()). The acid treatment can be carried out by the acid treatment, and there is no particular limitation on the effect of the present invention. The sulfuric acid is used in the second aspect, but the enzyme activity is less reduced in the acid treatment. In terms of §, it is preferably a weak acid. - The above weak acids include propylene glycol, acetic acid, scaly acid, etc. These weak acids are secreted by acetic acid and Wei Lin's highly toxic substances. The positive value at the time of the treatment is preferably 4 or more and 6 or less, and when the pH is 4.5 or more and 5.5 or less, the pH of the whole bacterial cell is uniform, and it is preferable to make the pH of the whole cell uniform. Further, the acid is slowly added. Further, before the acid treatment, the bacterial body is subjected to heat treatment. When the heat treatment is processed, it is easier to make the heat treatment temperature of the crushed product not more than the price. / more than 50C and 60. 〇 below. The heat treatment time of the broken body of the bacteria is more than 10 minutes or less, more preferably 5 minutes or more and 6g minutes. The above-mentioned acid treatment, that is, the cells subjected to the above step (7) Broken 201107479: Acid treatment The precipitated insoluble matter is removed (step (1)). It is presumed that if it is contained in (meth) acrylamide, it will affect the (meth) propyl group, and it is easy to make (meth) propyl (four) vesicles. A substance derived from a cell or a culture solution having a foaming property. When the foaming property of (meth)-Si amine is large, for example, when the compound f is polymerized (methylnaamine or the like), in order to eliminate two: Substances that are adversely affected, etc., sometimes enter the gland ~ / after the reaction, and the reaction of the beak into the c-amine treatment. At this time, the gas is blown into the (methyl) According to this, the amine has high foaming property, which leads to subsequent operation changes; in the operation of the device: in the operation of the amine, the (indenyl) propylene π: yl) propylene = material method can be listed, for example; The removal operation of the treated material may be carried out after the acid is treated, and the butyl ketone is preferably treated for a period of Λ 1 , (4) hours or less, more preferably 3 hours or more and ^^ hours or more. The opening limit is preferably carried out at 72. If the person wants to remove the lingering material, there is no special time. The following time is better for 48 hours =: step: : After the above step (1), the insoluble matter caused by the acid enters the test, and the test used in the process of 13 m. 201107479 can be suppressed as long as the effect of the present invention is not impaired. There is no particular limitation, and in terms of an inexpensive test, sodium hydroxide is preferred. The pH at the time of the alkali treatment is preferably a pH of 6 or more and 8 or less. The alkali treatment is the above step (4). Thereafter, the transition may be further carried out by using a microfiltration membrane (microfiltration membrane) and/or an ultrafiltration membrane (ultrafiltration membrane). The pore diameter of the MF filtration membrane is preferably 〇μμ1 or more and 2 μιη or less. More preferably, it is 0.1 μιη or more and 〇45 μιη or less, and more preferably 0.1 μιη or more and 0.2 μπι or less. Further, the material of the microfiltration membrane (MF membrane) and the ultrafiltration membrane (UF membrane) membrane is preferably a material which is adsorbed by a nitrile hydratase, and specifically, preferably polyvinylidene fluoride or polyethersulfone. Polysulfone, polyacrylonitrile. Method) and so on. Further, the filtration method using the above microfiltration membrane (MF membrane) and ultrafiltration membrane (UF membrane) is not particularly limited, and examples thereof include a dead end filtration method and a sweep filtration method (cr〇). Ss_fl〇w flltmti〇n, where there is a more reliable removal of the above insoluble matter, and the use of this micro-film (MF membrane), ultrafiltration membrane (UF membrane)

的性能造成影響的雜質的傾向。 另外,在藉由上述MF膜、及/或UFThe performance of the properties affects the tendency of impurities. In addition, by the above MF film, and/or UF

UF膜進行處理時,不僅過濾性得 、及對(甲基)丙烯酸胺 、及/或UF膜處理之前,可 。利用樹脂或助濾劑的處理形 疋床、流化床、懸浮床的 濾劑進行處理,則存在以 201107479, f改善’而且能更可靠地除去上述不溶物、及對(甲基)丙 烯醯胺的性能造成影響的雜質。 利用树月曰進行處理時所使用的樹脂較佳為可使用離子 交換樹脂,更料可使㈣陰料交換細旨。使用上述離 子父換樹脂時的緩衝液例如可列舉:加鹽酸緩衝液 酸缓衝液等。 另外,在利用離子交換樹脂將包含腈水合酶的菌體處 理物與雜質分離時’既可在腈水合酶吸附的條件下將包含 腈水合_8體處理物_質分離,亦可麵質吸附的條 件下將包含腈水合酶的菌體處理物與雜質分離。 將包含腈水合酶的菌體處理物吸附而使其溶析 (elution)時,可使用鹽,此鹽較佳為氯化納、氯化卸等。 鹽的濃度是腈水合酶溶析的濃度,較佳為敝福以上 2000 mM以下,更佳為2〇〇mM以上1〇〇〇mM以下。 助遽劑可列舉:石夕藻土、活性炭' 重晶石(barite)等。 上述助濾劑就腈水合酶活性的損失少的方面而言,較佳為 石夕藻土。 利用矽藻土進行處理時所使用的矽藻土較佳為Cd如 (碳酸鈉與經煅燒的矽藻土的混合物),CeUte中較佳When the UF film is treated, it is not only filterable, but also treated with (meth)acrylic acid amine and/or UF film. When treated with a resin or filter aid in the treatment of a boring bed, a fluidized bed or a suspension bed, there is an improvement in 201107479, f and the more reliable removal of the insoluble matter and the (meth) acrylonitrile Impurities that affect the performance of the amine. It is preferable to use an ion exchange resin for the resin to be used for the treatment of the tree sap, and it is more preferable to exchange the (4) cation exchange. The buffer solution in the case where the above-mentioned ion-retaining resin is used may, for example, be a hydrochloric acid buffer acid buffer or the like. In addition, when the cell treated material containing the nitrile hydratase is separated from the impurities by the ion exchange resin, the nitrile hydration _8 body treatment substance can be separated under the conditions of the nitrile hydratase adsorption, and the surface substance can be adsorbed. The bacterial material containing the nitrile hydratase is separated from the impurities under the conditions. When the cell treated material containing nitrile hydratase is adsorbed and eluted, a salt can be used, and the salt is preferably sodium chloride or chlorinated. The concentration of the salt is a concentration at which the nitrile hydratase is dissolved, and is preferably 2000 mM or less, more preferably 2 mM or more and 1 mM or less. Examples of the auxiliary agents include: Shixiazao soil, activated carbon 'barite, and the like. The above filter aid is preferably Shishizao soil in terms of a small loss of nitrile hydratase activity. The diatomaceous earth used in the treatment with diatomaceous earth is preferably Cd such as (a mixture of sodium carbonate and calcined diatomaceous earth), preferably in CeUte.

Celite 公司製造的 HYFLO SUPERCEL、Celite 5〇5。 ‘ 另外,本發明中,可將上述利用樹脂的處理 濾劑的處理加以組合。 』用助 藉由使用包含以上述方式獲得的游離的猜水合酶 體處理物,而可由腈化合物製造醯胺化合物,例如由(甲美) 15 201107479 丙烯腈製造(T基)丙烯醯胺。 上述(曱基)丙烯醯胺的製造通常在水性媒劑(叫此〇此 vehicle)中進行。此處’所謂水性媒劑,是指水,包含磷 酉欠I專的緩衝劑,以適當濃度溶解硫酸鹽或碳酸鹽等無機 鹽、鹼金屬的氫氧化物、或醯胺化合物等而得的水溶液。 本發明中,關於水性媒劑中的(甲基)丙烯腈的濃度, 在反應開始時此腈化合物的濃度並無特別限制,但太過量 的腈化合物的供給時,為使反應結束,而需要大量的觸媒 及具有過大容積的反應器、及用以除熱的過大的熱交換器 荨’於设備方面而言,經濟負擔變大。 因此,(甲基)丙烯腈的供給濃度在丙烯腈的情況下, 於此丙烯腈全部成為相對應的丙烯醯胺時,較佳為以相對 於反應益中的反應水溶液的總質量,丙烯醯胺的理論生成 液》辰度為40 wt%〜8 0 wt%的範圍的方式進行添加(曱基)丙 烯,,更具體而言,較佳為相對於水丨重量份而添加〇.4 重量份〜1.5重量份的範圍的丙烯腈。 、另外,在曱基丙烯腈的情況下,於此曱基丙稀腈全部 成為相對應的甲基丙烯醯胺時,較佳為以相對於反應器中 的反應水溶液的總質量,曱基丙烯醯胺的理論生成液濃度 為10 wt%〜40 Wt%的範圍的方式進行添加甲基丙稀腈,更 八體而。,較佳為相對於上述混合物中的水1重量份,而 添加0.08重量份〜0.5重量份的範圍的曱基丙烯腈。 另外,上述反應中的反應時間亦可受到觸媒使用量或 溫度等條件的左右,通常為丨小時〜12〇小時的範圍較 201107479HYFLO SUPERCEL and Celite 5〇5 manufactured by Celite. Further, in the present invention, the above treatment of the treatment filter using a resin can be combined. The guanamine compound can be produced from a nitrile compound by using a free hydrated lysate containing the material obtained in the above manner, for example, from (meth) 15 201107479 acrylonitrile (T-based) acrylamide. The production of the above (mercapto) acrylamide is usually carried out in an aqueous vehicle (so called this vehicle). Here, the term "aqueous vehicle" refers to water, which contains a buffer for phosphorus bismuth, and dissolves an inorganic salt such as a sulfate or a carbonate, a hydroxide of an alkali metal, or a guanamine compound at an appropriate concentration. Aqueous solution. In the present invention, the concentration of the (meth)acrylonitrile in the aqueous medium is not particularly limited as the concentration of the nitrile compound at the start of the reaction, but when the supply of the nitrile compound is too large, the reaction is required to be completed. A large amount of catalyst, a reactor having an excessively large volume, and an excessively large heat exchanger for removing heat have an economic burden in terms of equipment. Therefore, when the supply concentration of (meth)acrylonitrile is in the case of acrylonitrile, and when all of the acrylonitrile is the corresponding acrylamide, it is preferable to use propylene oxime relative to the total mass of the reaction aqueous solution in the reaction. The theoretical production liquid of the amine is added in a range of 40 wt% to 80 wt%, and more specifically, it is preferably added in an amount of 〇.4 by weight relative to the hydrazine part by weight. A portion of acrylonitrile in a range of ~1.5 parts by weight. Further, in the case of mercapto acrylonitrile, when all of the mercaptopropyl nitrile becomes the corresponding methacrylamide, it is preferably a mercapto propylene relative to the total mass of the reaction aqueous solution in the reactor. Methyl acrylonitrile is added in a manner in which the theoretical solution concentration of guanamine is in the range of 10 wt% to 40 Wt%. Preferably, the mercapto acrylonitrile is added in an amount of from 0.08 parts by weight to 0.5 parts by weight based on 1 part by weight of the water in the above mixture. Further, the reaction time in the above reaction may be affected by conditions such as the amount of catalyst used or temperature, and is usually in the range of 丨 hours to 12 〇 hours.

可進行連續式的反應。另外, 移動床等的任意一種。另外, 組合。 反應形式並無特舰定,可為批次式、半批次式, 反應器可為懸浮床、固定床、 可將多種形式的反應器加以 .“ΐ媒的使用量亦依存於反應條件,通常按此微生物乾A continuous reaction can be carried out. In addition, any of the moving bed and the like. In addition, the combination. The reaction form is not special, it can be batch type or semi-batch type, and the reactor can be a suspended bed, a fixed bed, and various types of reactors can be used. "The amount of the medium used depends on the reaction conditions. Usually dry by this microbe

另外,關於反應溫度,若為水性㈣的冰㈣上,則並益 特別限制,通常較佳為在0。〇〜5叱的範圍内進行,更^ 為10C〜4(TC的範圍。另外,亦可在產物於反應液中結晶 (crystallize)的漿料(siurry)狀態下進行反應。另外, 上述水合反應時的反應液的pH值只要可維持腈水合酶活 性’則並無特別限制,較佳為pH值為6〜1〇的範圍,更 藉由上述操作,可獲得每丨L的水溶液中包含蛋白質 較佳為0.1 mg〜50 mg、更佳為5 mg〜20 mg的(甲基)丙烯 醯胺水溶液。 另外,本發明中,蛋白質濃度是使用作為標準的隨附 的牛血清白蛋白(albumin ),藉由 Protein Assay ( Bi〇_Rad 公司製造)而求得。 即便包含上述範圍的此種蛋白質,亦未觀察到所得的 17 201107479 (甲基)丙烯醒胺水溶液的發泡,操作性優異,且使用此(甲 基)丙稀酿胺而得的(甲基)丙烯醯胺系聚合物為高品質。 另外’在上述(甲基)丙烯醯胺水溶液中,為丙烯醯胺 k ’較佳為含有40 wt%〜80 wt%的丙稀驢胺’為甲基丙烯 酿胺時’較佳為含有wt%〜4〇 wt%的曱基丙烯醯胺。 本發明的(甲基)丙烯醯胺系聚合物可藉由以下方式製 造:將以上述方式而得的(曱基)丙烯醯胺進行均聚合,或 將(甲基)丙烯醯胺與能和(曱基)丙烯醯胺共聚合的至少一 種不飽和單體進行共聚合。 能和(曱基)丙烯醯胺共聚合的不飽和單體可列舉: 丙烯酸、甲基丙烯酸、衣康酸、馬來酸、富馬酸等不 飽和缓酸及該些緩酸的鹽; 乙烯石黃酸、苯乙烯石黃酸、丙婦酿胺曱基丙確酸及該些 酸的鹽; 甲基丙烯酸-N,N-二曱基胺基乙酷(N,N-dimethylamino ethyl methacrylate )、曱基丙烯酸-N,N-二乙基胺基乙酯、丙 烯酸-N,N-二甲基胺基乙酯丙烯酸等(曱基)丙烯酸的烧基胺 基烷基酯,或者該些酯的四級銨衍生物; N,N-二甲基胺基丙基曱基丙烯醯胺、n,n_二甲基胺基 丙基丙烯醯胺等Ν,Ν-二烷基胺基烷基(甲基)丙烯醯胺、或 該些(甲基)丙烯酿胺的四級銨衍生物; 丙酮丙烯醯胺、Ν,Ν-二甲基丙烯醯胺、Ν,Ν_:甲基甲 基丙細酸胺、Ν-乙基甲基丙婦酿胺、Ν-乙基丙稀酿胺、νν_ 二乙基丙坤酿胺、Ν-丙基丙稀酿胺等親水性丙婦酿胺.Further, the reaction temperature is particularly limited in the case of ice (d) which is aqueous (d), and is usually preferably 0. It is carried out in the range of 〇~5叱, and is further in the range of 10C to 4 (TC). Alternatively, the reaction may be carried out in a state in which the product is crystallized in a liquid crystal. In addition, the above hydration reaction The pH of the reaction liquid is not particularly limited as long as the nitrile hydratase activity can be maintained, and it is preferably in the range of pH 6 to 1 Torr. Further, by the above operation, it is possible to obtain a protein contained in an aqueous solution per liter of L. Preferably, it is 0.1 mg to 50 mg, more preferably 5 mg to 20 mg of an aqueous solution of (meth) acrylamide. Further, in the present invention, the protein concentration is used as a standard accompanying bovine serum albumin (albumin). It is obtained by Protein Assay (manufactured by Bi〇_Rad Co., Ltd.) Even if the protein of the above range is contained, the obtained foam of the 17 201107479 (meth)acrylamide aqueous solution is not observed, and the workability is excellent. Further, the (meth)acrylamide polymer obtained by using the (meth)acrylamide is of high quality. Further, in the above (meth)acrylamide aqueous solution, it is preferably acrylamide k'. For containing 40 wt% to 80 wt% of acethanide When it is a methacrylic amine, it is preferably a fluorenyl acrylamide containing from wt% to 4% by weight. The (meth) acrylamide polymer of the present invention can be produced by the following means: The methacrylamide obtained by the method is homopolymerized or copolymerized with at least one unsaturated monomer copolymerizable with (fluorenyl) acrylamide. Examples of the unsaturated monomer copolymerized with fluorenylamine can be exemplified by unsaturated acid such as acrylic acid, methacrylic acid, itaconic acid, maleic acid, and fumaric acid, and salts of such acid retardants; , styrene-refluoric acid, propylene-based amino-propionic acid and salts of the same; methacrylic acid-N,N-dimethylamino ethyl methacrylate, sulfhydryl An alkylaminoalkyl (meth) acrylate such as N,N-diethylaminoethyl acrylate or N-N-dimethylaminoethyl acrylate or the like Ammonium derivative; N,N-dimethylaminopropylmercaptopropenylamine, n,n-dimethylaminopropylpropenylamine, etc., hydrazine-dioxane Aminoalkyl (meth) acrylamide, or a quaternary ammonium derivative of the (meth) acrylamide; acetone acrylamide, hydrazine, hydrazine-dimethyl methacrylate, hydrazine, hydrazine Hydrophilic women such as methyl methacrylate, Ν-ethyl methacrylate, Ν-ethyl propyl amide, νν_ diethyl propyl uranium, Ν-propyl propyl amide Stuffed amine.

18 201107479 N-丙晞醯基*各唆、N-丙_基«、㈣_基嗎 淋(N-acryloyl morpholine ); 甲基丙婦酸經基乙酉旨、丙烯酸經基乙酉旨、甲基 羥基丙酯、丙烯酸羥基丙酯; 甲氧基聚乙二醇(甲基)丙烯酸酉旨、N_乙稀基_2· 酮; N,N-二正丙基丙烯酿胺、N•正丁基丙稀酿胺、N_正己 基丙烯酿胺、N-正己基曱基丙_胺、& 胺、N-正辛基甲基丙烯醯胺、N,三辛基丙烯醯ς、:: -烧基丙烯gi胺、&正十二⑥基f基 (曱基)丙烯醯胺衍生物; 心N沉基 n,n-,縮水甘油基丙烯酿胺(n,n_ ΓΓ:?)、N具二縮水甘油基甲基丙婦醯胺、N-(4'縮水 1油乳基丁基)丙烯_、N-(4'缩水甘油氧基丁基)甲基丙 稀,、N_(5'财甘油氧基錢)㈣ϋ胺、Ν·(6·縮水甘 油氧基己基)丙烯醯胺等Ν_(ω_縮水甘油氧基烷基)(曱基)丙 烯醯胺衍生物; t(甲基)丙稀酸甲酯、(曱基)丙烯酸乙酯、(甲基)丙稀酸 丁酉曰、(甲基)丙烯酸月桂酯、(曱基)丙烯酸2-乙基己酯、(甲 基)丙稀,縮水甘*酉旨等(曱基)丙烯酸醋衍生物; <丙烯猜、甲基丙歸腈,乙酸乙烯酷,氯乙烯、偏二氯 ^烯乙烯、_、丁埽等稀烴類’苯乙稀、α_曱基 烯,丁二烯、異戊二烯等。 該些單體可單獨使用1種,亦可併用2 種以上。 19 ^t. 201107479 該些單體的聚合方法 該些之中,為水溶液取人有谷液聚合、乳化聚合等。 ,加的傷單 ===由基聚合起始劑。 氧化Γ酸却、過硫酸録、過氧化氫、過氧化笨甲酿等過 IL^km~m 將上Λ )等減系自域起始劑; 將上述過氧化物與亞硫酸二 銨等所謂氧化還原(re-以 上述來合起始劑可單獨使用丨種,亦可併 聚^始劑的量通常相對於單體的總f量 ° 〜5 wt%的範圍。 勹υ.υιη wt/〇 〜合鬥显度#,在為單一聚合起始劑時,通常為〇ΐ 产往独Ϊ 為穴〜听的範圍。另外,聚合溫 f甬持為固技度’可隨著聚合的進行而適當變 隨者聚合的進行,會產生聚合熱而有 升的傾向,因此視需要有時亦進行冷卻。 又 ^聚合時的環境氣體並無特別限定,就迅速進行 觀點而言,較佳為例如在氮㈣惰減 °、 圍。聚合時_特觀定,通…㈣〜 201107479 口另外,聚合時的水溶液的pH值亦無特別限定,祝需 要可調值而進行聚合。此時可使用的阳值調赞剩可 ,舉.氫氧化鈉、氫氧化鉀、氨等鹼;磷酸、硫酸、礬酸 等無機酸;甲酸、乙酸等有機酸等。 爪 木、糟由本發明而得的聚合物的分子量並無特別限制,通 韦為10萬〜5000萬的範圍,較佳為5〇萬〜如⑽萬的範圍。 β、以上述方式而得的本發明的(曱基)丙烯醯胺系聚合物 疋兼具水溶性與高分子量的聚合物,且色調優異,町適合 用作凝聚劑、製紙用添加劑、石油时劑等 實例 以下,根據實例對本發明進行更具體地說明,俱本發 明不文忒些貫例限定。以下,只要無特別說明,%、ppm 為質量基準。 [丙烯醯胺、曱基丙烯醯胺的分析] 各實例及比較例、參考例中的高效液相層析法 (HPLC,high perf〇nnance liquidchr〇mat〇graphy)分析是18 201107479 N-acrylic acid*, N-propyl_yl«, (4)_N-acryloyl morpholine; methyl acetoacetate by acetylacetate Propyl ester, hydroxypropyl acrylate; methoxy polyethylene glycol (meth) acrylate, N-ethylene-2, ketone; N, N-di-n-propyl acrylamide, N• n-butyl Propylene amine, N_n-hexyl acrylamide, N-n-hexyl decyl propylamine, & amine, N-n-octyl methacrylamide, N, trioctyl propylene fluorene, :: Pyridyl propylene giamine, & n-dodecyl-6-f-yl (fluorenyl) acrylamide derivative; heart N-n-based n, n-, glycidyl acrylamide (n, n_ ΓΓ:?), N With diglycidylmethylpropanolamine, N-(4'shrinked 1 oleyl butyl butyl) propylene, N-(4' glycidoxybutyl) methyl propylene, N_(5'四 甘油 氧基 钱 ) ( 四 四 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( Methyl acrylate, ethyl (meth) acrylate, (methyl) acetonate, ( Methyl)lauryl acrylate, 2-ethylhexyl (meth) acrylate, (meth) propylene, condensed glucosinolate, etc.; <acrylic guess, methyl propyl Nitrile, vinyl acetate, vinyl chloride, vinylidene chloride, _, butyl hydrazine and other dilute hydrocarbons such as styrene, α-mercapto, butadiene, isoprene, etc. These monomers may be used alone or in combination of two or more. 19 ^ t. 201107479 Polymerization method of these monomers Among them, there are liquid solution polymerization, emulsion polymerization, and the like for the aqueous solution. , added injury list === from the base polymerization initiator. Γ Γ 却 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 Redox (re- can be used alone or in combination with the above-mentioned initiators, and the amount of the polymerization agent is usually in the range of ~5 wt% relative to the total amount of the monomers. 勹υ.υιη wt/ 〇~合斗显度#, when it is a single polymerization initiator, it is usually 〇ΐ 产 Ϊ Ϊ Ϊ 〜 听 听 ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ In the case where the polymerization proceeds appropriately, the polymerization heat tends to rise, so that it may be cooled as occasion demands. The ambient gas during the polymerization is not particularly limited, and it is preferably from the viewpoint of rapid progress. For example, in the case of nitrogen (tetra), the concentration of the nitrogen is reduced, and the polymerization is carried out. (4) ~ 201107479. In addition, the pH of the aqueous solution during polymerization is not particularly limited, and it is necessary to carry out polymerization by adjusting the value. The positive value of the yang can be praised, such as sodium hydroxide, potassium hydroxide, ammonia and other alkali; phosphoric acid, sulfuric acid, citric acid Inorganic acid; organic acid such as formic acid or acetic acid, etc. The molecular weight of the polymer obtained by the present invention is not particularly limited, and the flux is in the range of 100,000 to 50 million, preferably 50,000 to 10,000. In the above-mentioned manner, the (fluorenyl) acrylamide-based polymer of the present invention has a water-soluble and high molecular weight polymer, and has excellent color tone, and is suitable as a coagulant and an additive for papermaking. Examples of petroleum time agents and the like Hereinafter, the present invention will be more specifically described based on examples, and the present invention is not limited to the following examples. Unless otherwise specified, % and ppm are based on mass standards. [Propylene amide, sulfhydryl group Analysis of acrylamide] High performance liquid chromatography (HPLC, high perf〇nnance liquidchr〇mat〇graphy) analysis in each example and comparative example and reference example is

使用,日本分光製造的Finepak SIL C18_5 (25㈣6 〇娜) 作為管柱’使用包含4V0l%(體積百分比)的乙腈的1〇mM %酉夂水冷液作為展開液。另外,丙稀醒胺、甲基丙歸酿胺 藉由220 nm的吸光度進行檢測。 [製造例1] [菌體的製備] 依據日本專利特開2._91號的實例1所記載的 方法,以日本專利特開平的―中所得的ρρτ•腦質 21 201107479 體DNA為模板’而取得曰本專利特開平09-275978的實例 1表3所記載的Νο·3選殖菌體。具有pPT-DBl質體的大腸 菌是MT-10822株(寄存編號FERM BP-5785),如上所述 寄存在專利生物寄存中心。在經南種蒸氣滅菌的包含〇.1 g/L的FeS〇4、及0·05 g/L的CoCl2的LB培養基中以達到 0.1 mg/L的方式添加女比西林(ampicillin)。製作預痒養 所用的培養基200 ml ’於此培養基中植菌一白菌耳的^述 的No.3選殖菌體’在33°C的溫度下進行預培養。藉由濁 度測定法以把握預培養時的菌體的增殖量,在66〇 nm的 吸光度為3.G〜6.G的範__結束預培養。將預培 得的培養液植菌於經高壓蒸氣減g過的表丨所示的^ 養時所用的培養基5 L中,在抑的溫度下—邊以1〇 = 將空氣向培養_通氣-邊進行麟,進行48小時正 養而獲得培養液(細胞懸浮液)。另外,自 = 開始起監視培養液的pH值,在阳值為°養9 °養 牧Prt值為7.45以上時馬味 30分鐘添加15 ml的500 g/L的葡萄糖。 了歷呀 [表1]Using Finepak SIL C18_5 (25 (4) 6 〇 Na) manufactured by JASCO Corporation, as a column column, a 1 mM % water-cooled liquid containing 4 0.001% by volume of acetonitrile was used as a developing solution. In addition, acrylamide and methyl propylamine were detected by absorbance at 220 nm. [Production Example 1] [Preparation of the bacterial cell] According to the method described in Example 1 of Japanese Patent Laid-Open No. 2.-91, the ρρτ• brain quality 21 201107479 DNA obtained in the Japanese Patent Application No. The Νο·3 bacterium selected in Table 3 of Example 1 of JP-A-09-275978 was obtained. The Escherichia coli having the pPT-DB1 plastid is the MT-10822 strain (Accession No. FERM BP-5785), which is deposited in the Patent Biological Depository Center as described above. Ibicillin was added in a LB medium containing 〇.1 g/L of FeS〇4 and 0.05 g/L of CoCl2 by steam sterilization in the south to achieve 0.1 mg/L. 200 ml of the medium for pre-itching was prepared. The No. 3-selected cells of the bacterium, which was incubated with the bacterium, were pre-cultured at a temperature of 33 °C. The turbidity measurement method was used to grasp the amount of growth of the cells at the time of pre-culture, and the pre-culture was terminated at a concentration of 3. G to 6. G at a concentration of 66 〇 nm. The pre-cultured culture solution is sterilized in 5 L of the medium used for the maintenance of the high-pressure steam-reduced table, at a temperature of -1 〇 = air to culture_ventilation - The broth was carried out for 48 hours to obtain a culture solution (cell suspension). In addition, the pH of the culture solution was monitored from the beginning of the test, and 15 ml of 500 g/L of glucose was added to the horse for 30 minutes when the positive value was 9 ° and the Prt value was 7.45 or more. The calendar [Table 1]

201107479 [實例1] [由菌體製備包含游離的腈水合酶的菌體處理物] (利用均質器破碎菌體) 使用SANWA ENGINEERING股份有限公司製造的均 貝器H50 ’在溫度15。〇、破碎壓力50 MPa、破碎時間1〇〇 分鐘的條件下,將上述製造例1中製備的培養液5丄所含 的菌體破碎’而製作使菌體所含的腈水合酶游離在溶液中 的破碎溶液。 (熱處理) 將上述破碎溶液移至10 L的玻璃燒杯中,一邊將破碎 浴液充分攪拌,一邊將玻璃燒杯浸潰在5〇。〇的水浴恆溫槽 中。在破碎溶液的液溫達到5(TC後再繼續浸潰15分鐘, 然後取出燒杯在空氣中冷卻。 (利用酸析出雜質) 在充分擾拌的上述熱處理後的破碎溶液中,緩慢添加 2 Μ乙酸水溶液,直至溶液的pH值達到5〇為止,另外, 將此/谷液搜拌3小時而使雜質析出。 (藉由離心分離除去破碎物等) 使用離心機(日立工機股份有限公司製造:CR22G), f 15<〇、⑽⑻印瓜、15分鐘的條件下,將上述利用酸進行 Ϊ理的破碎液進行離心分離,將藉由添加酸而析出的雜質 寺除去,而獲得離心上清液。 (離心上清液的中和) 在充刀授拌的上述離心上清液中缓慢添加1 Μ的 23 201107479 X丄201107479 [Example 1] [Preparation of a bacterial material containing free nitrile hydratase from a bacterial cell] (The bacterial cell was disrupted by a homogenizer) A homogenizer H50' manufactured by SANWA ENGINEERING Co., Ltd. was used at a temperature of 15. Under the conditions of a crushing pressure of 50 MPa and a crushing time of 1 minute, the cells contained in the culture solution prepared in the above Production Example 1 were crushed, and the nitrile hydratase contained in the cells was dissolved in the solution. The broken solution in the medium. (Heat treatment) The above-mentioned crushed solution was transferred to a 10 L glass beaker, and the glass beaker was immersed in 5 Torr while the crushing bath was sufficiently stirred. The water bath is in the bath. After the liquid temperature of the crushing solution reaches 5 (TC), the impregnation is continued for 15 minutes, and then the beaker is taken out and cooled in the air. (Precipitation of impurities by acid) Slowly add 2 Μ acetic acid in the crushed solution after the above-mentioned heat treatment which is sufficiently disturbed The aqueous solution was allowed to stand until the pH of the solution reached 5 Torr, and the solution was mixed for 3 hours to precipitate impurities. (Removal of the crushed material by centrifugation, etc.) Using a centrifuge (manufactured by Hitachi Industrial Co., Ltd.: CR22G), f 15 < 〇, (10) (8) Inoculum, under the condition of 15 minutes, the above-mentioned crushed liquid subjected to acid treatment was centrifuged, and the impurity precipitated by the addition of acid was removed to obtain a centrifugal supernatant. (Neutralization of Centrifugal Supernatant) Slowly add 1 Μ of 23 in the above-mentioned centrifugation supernatant mixed with a knife. 2011/07479 X丄

NaOH直至溶液的pH值達到7 ο Α , •為止,而將離心上清液中 和0 另外’在不貫施此中和的情況υ ^ , w月/凡下,由於雜質的析出而 無法進彳丁後一步驟的MF過濾、。 (中和液的MF過濾) <7 450 (DFC 膠囊型), 離心上清液過濾。 使用Poul公司製造的只一求 在0,5 MPa的條件下,將上述中和的 (過濾液的濃縮) 使用旭化成公司製造的 ^ ^ 、;Pencil刑中空絲用 AHP-0013,在平均壓力〇.1MPa 叫坐Τ ; ,.y, 備%速度 1.5 mm/sec 白 條件下,進行5倍濃縮而獲得菌體處理 (蛋白質濃度的測定) i體處理物的蛋白質漢度是使用㈣偷八啊 公司_進行測定。標準是使用隨附的牛血 >月白蛋白。敎結果是菌體處理物中的蛋白質濃度為% mg/ml。 [丙烯醯胺的製造] 準備具備攪拌器的1 L玻璃製燒瓶作為第1反應器, 準備内徑為5 mm的TeflQn (註冊商標)製管2() m作為第 二反應器。在第一反應器中預先投入4〇〇g水。 將藉由上述方法而製備的菌體處理物〇 〇3 wt%懸浮於 0.3 mM_NaOH水溶液中。一邊對此懸浮液與丙烯腈進行攪 拌,一邊分別以49 g/h、31 g/h的速度向第i反應器中連 續地進料。接著,以將第丨反應器的液面水平保持固定的 24 S· 201107479 方式,將反應液自第1反應器以80 g/h的速度連續地抽 出。將此抽出的反應液以80 g/h的速度向第2反應器連續 地進料,在第2反應器内進一步進行反應。 α 苐1反應器及弟2反應器均浸潰在1 〇°c〜2〇〇c的溫产 水浴中,並以使各反應器内部的液溫為15。〇的方式進行溫 度控制。 ^ 调整囟體處理物相對於0.3 mM-NaOH水溶液的添加 量,以使第1反應器出口的向丙烯醯胺的轉化率為9〇%以 上,且第一反應為出口的丙烯腈濃度為檢測極限以下( ppm以下)。向丙烯醯胺的轉化率是根據HpLC的分析結 果而求得。所得的丙烯醯胺水溶液中添加2 v[的丙烯酸而 調整成pH值為7。另外,對所得的丙烯醯胺水溶液令所含 的蛋白質進行分析。蛋白質濃度是在利用半透膜 (Spectra/Por截留分子量1000)將丙烯醯胺水溶液中所含 的丙烯醯胺透析除去後,使用protein Assay(Bi〇-Rad公司 衣)進行測疋的。所得的丙稀酿胺水溶液的1 kg中所存 在的蛋白質量為10 mg,與根據上述菌體處理物的蛋白質 濃度、及上述菌體處理物的添加量計算而得的值相同。 [丙烯醯胺水溶液的發泡試驗] 將藉由上述方法而得的丙稀驢胺水溶液300 g加入至 500ml量筒中。於此丙烯醯胺水溶液中導入木下式玻璃球 過遽器503G,自量筒底部通過此過濾器,以900 ml/min 吹入空氣,測定經過5分鐘的時刻的發泡的高度。 結果是丙烯酿胺水溶液的發泡小於1〇 而幾乎未 25 201107479 觀察到,為非常良好的結果。 [實例2] 使用2Μ丙烯酸水溶液替代2Μ乙酸水溶液來進行實 例1中的利用酸析出雜質,除此以外,進行與實例1相同 的操作,而獲得菌體處理物、及丙烯醯胺水溶液。在所得 的丙烯醯胺溶液的1 kg中所存在的蛋白質量為1〇 mg。 以與實例1相同的方式,進行丙烯醯胺水溶液的發泡 試驗,結果是丙婦醯胺水溶液的發泡小於1 〇 mm而幾乎未 觀察到,為非常良好的結果。 [實例3] 使用2Μ磷酸水溶液替代2Μ乙酸水溶液來進行實例 1中的利用酸析出雜質,除此以外,進行與實例1相同的 知作’而獲得囷體處理物、及丙婦酿胺水溶液。在所得的 丙烯醯胺溶液的1 kg中所存在的蛋白質量為1〇 mg。 以與實例1相同的方式,進行丙烯醯胺水溶液的發泡 试驗’結果是丙稀酿胺水溶液的發泡小於1 〇 mm而幾乎未 觀察到,為非常良好的結果。 [實例4] 使用2Μ硫酸水溶液替代2Μ乙酸水溶液來進行實例 1中的利用酸析出雜質,除此以外,進行與實例1相同的 操作,而獲得菌體處理物、及丙烯醯胺水溶液。在所得的 丙烯醯胺溶液的1 kg中所存在的蛋白質量為8 mg。 以與實例1相同的方式,進行丙烯醯胺水溶液的發泡 5式驗,結果是丙歸酿胺水溶液的發泡小於10 mm而幾乎未NaOH until the pH of the solution reaches 7 ο Α , • until the centrifugation supernatant neutralizes 0. In addition, in the case of non-compliance with this neutralization υ ^ , w month / where, due to the precipitation of impurities can not enter MF filtration after a step in Kenting. (MF filtration of neutralizing solution) <7 450 (DFC capsule type), centrifuge supernatant to filter. Using the only one manufactured by Poul, the neutralization (concentration of the filtrate) was carried out under the conditions of 0,5 MPa using the ^^, manufactured by Asahi Kasei Co., Ltd.; Pennel was used for AHP-0013, at an average pressure〇 .1MPa is called Τ; ,.y, preparation speed is 1.5 mm/sec. Under white conditions, 5 times concentration is obtained to obtain bacterial treatment (measurement of protein concentration). The protein Han of the body treatment is used (4) Company _ conduct the measurement. The standard is to use the accompanying bovine blood > lunar albumin. The result is that the protein concentration in the bacterial treatment is % mg/ml. [Production of acrylamide] A 1 L glass flask equipped with a stirrer was prepared as a first reactor, and a TeflQn (registered trademark) tube 2 () m having an inner diameter of 5 mm was prepared as a second reactor. 4 g of water was previously charged in the first reactor. The cell treatment 〇 3 wt% prepared by the above method was suspended in a 0.3 mM aqueous solution of NaOH. While stirring this suspension with acrylonitrile, the suspension was continuously fed to the i-reactor at a rate of 49 g/h and 31 g/h, respectively. Next, the reaction liquid was continuously withdrawn from the first reactor at a rate of 80 g/h in a manner of 24 S·201107479 in which the liquid level of the second reactor was kept constant. The extracted reaction liquid was continuously fed to the second reactor at a rate of 80 g/h, and the reaction was further carried out in the second reactor. Both the α 苐 1 reactor and the 2 reactor were immersed in a temperature-producing water bath of 1 〇 ° c 2 2 〇〇 c so that the liquid temperature inside each reactor was 15. The temperature is controlled in a sly way. ^ Adjusting the addition amount of the steroid treatment to the 0.3 mM-NaOH aqueous solution so that the conversion rate of the first reactor outlet to acrylamide is 9% or more, and the first reaction is the outlet acrylonitrile concentration for detection. Below the limit (below ppm). The conversion to acrylamide was determined based on the analysis results of HpLC. To the obtained aqueous solution of acrylamide, 2 v [acrylic acid was added to adjust the pH to 7. Further, the obtained acrylamide aqueous solution was subjected to analysis of the contained protein. The protein concentration was measured by dialysis and removal of acrylamide contained in an aqueous solution of acrylamide using a semipermeable membrane (Spectra/Por molecular weight cutoff of 1000), and then measurement was carried out using a Protein Assay (Bi〇-Rad Co., Ltd.). The amount of protein present in 1 kg of the obtained aqueous solution of acrylamide was 10 mg, which was the same as the value calculated based on the protein concentration of the cell-treated material and the amount of the cell-treated material. [Foaming test of aqueous acrylamide solution] 300 g of an aqueous solution of acrylamide obtained by the above method was placed in a 500 ml measuring cylinder. Into the acrylamide aqueous solution, a wood-type glass ball filter 503G was introduced, and the bottom of the measuring cylinder was passed through the filter, and air was blown at 900 ml/min, and the height of foaming at the time of 5 minutes was measured. As a result, the foaming of the aqueous acrylamide solution was less than 1 Torr and almost no observed in 201107479, which was a very good result. [Example 2] A cell treated product and an aqueous solution of acrylamide were obtained by the same operation as in Example 1 except that the aqueous solution of 2 hydrazine was used instead of the aqueous solution of acetic acid. The amount of protein present in 1 kg of the obtained acrylamide solution was 1 〇 mg. In the same manner as in Example 1, a foaming test of an aqueous solution of acrylamide was carried out, and as a result, the foaming of the aqueous solution of the potassium sulphate was less than 1 〇 mm and was hardly observed, which was a very good result. [Example 3] A steroid treated product and an aqueous solution of propylene sulphate were obtained by performing the same procedure as in Example 1 except that the aqueous solution of 2 hydrazine phosphate was used instead of the aqueous solution of hydrazine acetate. The amount of protein present in 1 kg of the obtained acrylamide solution was 1 mg. In the same manner as in Example 1, the foaming test of the aqueous acrylamide solution was carried out. As a result, the foaming of the aqueous solution of the acrylamide was less than 1 〇 mm and was hardly observed, which was a very good result. [Example 4] The same operation as in Example 1 was carried out, except that a 2 Μ aqueous solution of sulfuric acid was used instead of the aqueous solution of acetic acid in Example 2, and the same procedure as in Example 1 was carried out to obtain a cell treated product and an aqueous solution of acrylamide. The amount of protein present in 1 kg of the obtained acrylamide solution was 8 mg. In the same manner as in Example 1, the foaming of the aqueous acrylamide solution was carried out, and as a result, the foaming of the aqueous solution of the acrylamide was less than 10 mm and almost no

26 S 201107479 觀察到,為非常良好的結果。 另外,在實例1〜3的利用乙酸、丙烯酸、磷酸(弱酸) 析出雜質時,未觀察到腈水合酶活性的降低。另一方面, 在利用硫酸(強酸)析出雜質的本實例4時,觀察到猜水 合酶活性降低25%左右。 [實例5] 除了不實施實例1的熱處理以外,進行與實例丨相同 的操作,而獲得菌體處理物、及丙烯醯胺水溶液。在所得 的丙烯醯胺溶液的1 kg中所存在的蛋白質量為1〇mg。 以與實例1相同的方式,進行丙烯醯胺水溶液的發泡 試驗,結果是丙烯醯胺水溶液的發泡小於1〇mm而幾乎未 觀察到’為非常良好的結果。 [實例6] ^ 在只例1中的離心上清液的中和後,進行以下記載的 離=交,樹脂處理’並進行中和液的MF過濾,除此以外, 實例1相同的操作,而獲得菌體處理物、及丙婦酿 胺水溶液。在所得的丙烯醯胺溶液的lkg中所存在的蛋白 質量為5 mg。 &、以與貫例1相同的方式,進行丙烯醯胺水溶液的發泡 、°果疋丙~醯胺水溶液的發泡小於10 mm而幾乎未 觀察到,為^良好的結果。 成子未 (綠子父換樹脂處理) 使用作為強陰離子交換樹脂的26 S 201107479 Observed, very good results. Further, when impurities were precipitated by acetic acid, acrylic acid or phosphoric acid (weak acid) in Examples 1 to 3, no decrease in nitrile hydratase activity was observed. On the other hand, in the present Example 4 in which impurities were precipitated by sulfuric acid (strong acid), it was observed that the hydrolytic enzyme activity was decreased by about 25%. [Example 5] The same operation as in Example 进行 was carried out except that the heat treatment of Example 1 was not carried out, and a bacterial cell treated product and an aqueous solution of acrylamide were obtained. The amount of protein present in 1 kg of the obtained acrylamide solution was 1 〇 mg. In the same manner as in Example 1, a foaming test of an aqueous solution of acrylamide was carried out, and as a result, foaming of the aqueous solution of acrylamide was less than 1 mm and almost no observation was made as a very good result. [Example 6] ^ After the neutralization of the centrifugation supernatant in Example 1, the same operation as in Example 1 was carried out, except that the following treatment was carried out, resin treatment was carried out, and MF filtration of the neutralization liquid was performed. The obtained bacterial material and the aqueous solution of the acrylic acid amine were obtained. The protein present in the lkg of the resulting acrylamide solution was 5 mg. &, in the same manner as in Example 1, the foaming of the aqueous acrylamide solution was carried out, and the foaming of the aqueous solution of the aqueous solution of the phthalocyanine to the guanamine was less than 10 mm, which was hardly observed, and was a good result. The child is not used (green child is replaced by resin). It is used as a strong anion exchange resin.

Bio-Rad公司製造的 0 sphere Q。準備樹脂量為5〇〇血的樹脂塔,以%瓜% 27 5.0 sphere Q manufactured by Bio-Rad. Prepare a resin tower with a resin content of 5 〇〇 blood, with % 瓜% 27 5.

XX 201107479 構酸緩衝液(pH值為7.0) 2.5 L進行充分平衡。然後,進 行與實例1相同的操作,將所得的經令和的離心上清液2.5 L供給至上述樹脂塔並使腈水合酶吸附。然後,以5〇mM 磷酸緩衝液(pH值為7.0) 2.5 L進行清洗後,在50 mM 鱗酸緩衝液(pH值為7.0)中以達到0·2 Μ的方式添加 NaCl ’藉由所得的溶液使腈水合酶溶析,而獲得經離子交 換樹脂處理的離心上清液。 [實例7] 在實例1中的離心上清液的中和後,進行以下記載的 Celite處理,並進行中和液的MF過濾,除此以外,進行 與實例1相同的操作,而獲得菌體處理物、及丙烯醯胺水 溶液。在所得的丙烯醯胺溶液的1 kg中所存在的蛋白質量 為 9 mg。 以與實例1相同的方式,進行丙烯醯胺水溶液的發泡 試驗’結果是丙稀醯胺水溶液的發泡小於10 mm而幾乎未 觀察到’為非常良好的結果。 (Celite 處理)XX 201107479 Phytic acid buffer (pH 7.0) 2.5 L for adequate equilibration. Then, the same operation as in Example 1 was carried out, and 2.5 L of the obtained centrifuged supernatant was supplied to the above resin column to adsorb the nitrile hydratase. Then, after washing with 2.5 mM of 5 mM phosphate buffer (pH 7.0), NaCl was added in a 50 mM sulphate buffer (pH 7.0) to achieve 0·2 藉. The solution was allowed to elute the nitrile hydratase to obtain an ion exchange resin-treated centrifugal supernatant. [Example 7] After the neutralization of the centrifugation supernatant in Example 1, the Celite treatment described below was carried out, and MF filtration of the neutralization liquid was carried out, except that the same operation as in Example 1 was carried out to obtain a bacterial cell. The treated material and the aqueous solution of acrylamide. The amount of protein present in 1 kg of the obtained acrylamide solution was 9 mg. In the same manner as in Example 1, the foaming test of the aqueous acrylamide solution was carried out. As a result, the foaming of the aqueous acrylamide solution was less than 10 mm and almost no observation was made, which was a very good result. (Celite processing)

Celite 是使用 Celite 公司製造的 HYFLO SUPERCEL。 進行與實例1相同的操作,在所得的經中和的離心上清液 中以達到3 wt%的方式添加HYFLO SUPERCEL,並在15°C 下攪拌3小時,然後,使用東洋濾紙No.2進行抽吸過濾, 而獲得經Celite處理的離心上清液。 [實例8] 將所使用的Celite替代為Celite 505 ’除此以外,進行Celite is a HYFLO SUPERCEL manufactured by Celite. The same operation as in Example 1 was carried out, and HYFLO SUPERCEL was added in the obtained neutralized centrifugal supernatant to a ratio of 3 wt%, and stirred at 15 ° C for 3 hours, and then, using Toyo Filter Paper No. 2 The filtrate was filtered under suction to obtain a Celite-treated centrifugal supernatant. [Example 8] The Celite used was replaced with Celite 505', except for

28 201107479 。只例7相同的才木作,而獲得菌體處理物、及丙稀酿胺水 =液。在所得的丙_胺溶液的1 kg中所存在的蛋白質量 為 9 mg。 以與貝例1相同的方式,進行丙烯醯胺水溶液的發泡 試驗,結果是丙_胺水溶液的發泡小於10 mm而幾乎未 觀察到,為非常良好的結果。 [比較例1] 不實施實例1中的利用酸析出雜質、及離心上清液的 和’除此以外’進行與實例i相同喃作,而獲得菌體 :理物、及丙賴胺水溶液。所得的㈣處理物的蛋白質 /辰度為300 mg/m卜另外,在所得的丙稀驢胺溶液的i 中所存在的蛋白質量為6〇 mg。 &以與貫例1相同的方式’進行丙烯酿胺水溶液的發泡 試驗,結果是丙烯酿胺水溶液的發泡為⑽顏以上,無 法製成製品使用而不良。 [參考例1] —、進行與比較例1相同的操作,在所製造的丙烯醯胺水 办液中添加2 Μ丙烯酸水溶液,而製備將pH值調整為5 的水溶液,並在此水溶液中添加〇4 wt%的活性炭(三倉 化成股份有限公司製造的粉末活性炭pM_sx),在25。〇下 攪拌5小時。然後,使用濾紙進行過濾將活性炭除去,並 添加1 Μ的NaOH水溶液,將所得的水溶液的pH值調整 為7 ’而製作經中和的濾液。 測定此經中和的濾液中的蛋白質濃度。蛋白質濃度是 29 201107479 在利用半透膜(Spectra/Por截留分子量10〇〇)將此濾液中 所含的丙烯酿胺透析除去後,使用Amic〇n uiira_15 (Millpore公司製造的截留分子量3〇〇〇)濃縮為1〇〇倍, 使用Protein Assay (Bio-Rad公司製造)進行測定。在所得 的丙烯醯胺水溶液的1 kg中所存在的蛋白質量小於 mg。 以與貫例1相同的方式,進行丙婦酿胺水溶液的發泡 試驗’結果是丙烯醯胺水溶液的發泡為1〇 mm,為良好的 結果。 [參考例2] 在藉由與參考例1相同的操作而得的丙烯醯胺水溶液 中,以在丙稀醯胺水溶液的1 kg中所存在的蛋白質濃度為 10 mg的方式,添加藉由與比較例丨相同的操作而製備的 菌體處理物,。 以與實例1相同的方式,進行丙烯酿胺水溶液的發泡 試驗,結果是在未進行酸處理的菌體處理物時,丙烯醯胺 水溶液的發泡為100 mm以上,無法製成製品使用而不良。 .[參考例3] 使用0.3 mM-NaOH水溶液及第一化學藥品公司製造 的電泳用丙烯醯胺(純度99.9%),而製備52 wt%的丙烯 醯胺水溶液’在此水溶液中添加2Μ的丙烯酸水溶液,而 獲得pH值調整為7的丙烯醯胺水溶液。 以與實例1相同的方式,進行丙烯醯胺水溶液的發泡 試驗,結果是所得的丙烯醯胺水溶液的發泡小於10mm而28 201107479. Only the same wood was used in Example 7, and the bacterial material treatment and the acrylonitrile water = liquid were obtained. The amount of protein present in 1 kg of the resulting propylamine solution was 9 mg. The foaming test of the aqueous solution of acrylamide was carried out in the same manner as in the case of the shell example 1. As a result, the foaming of the aqueous solution of the aqueous solution of the azamine was less than 10 mm and was hardly observed, which was a very good result. [Comparative Example 1] The same procedure as in Example i was carried out without using the acid-precipitating impurities and the centrifugation supernatant in Example 1, and the same conditions as in Example i were carried out to obtain a bacterial material: a physiological substance, and an aqueous solution of propidium. The protein (minus) of the obtained (iv) treated product was 300 mg/m. Further, the amount of protein present in i of the obtained acesulfame solution was 6 〇 mg. & A foaming test of the aqueous acrylamide aqueous solution was carried out in the same manner as in Example 1. As a result, the foaming of the aqueous acrylamide aqueous solution was (10) or more, which was not preferable because it was not used as a product. [Reference Example 1] - The same operation as in Comparative Example 1 was carried out, and an aqueous solution of 2 Torr of acrylic acid was added to the produced acrylamide aqueous solution to prepare an aqueous solution having a pH adjusted to 5, and was added to the aqueous solution. 〇 4 wt% of activated carbon (powder activated carbon pM_sx manufactured by Sancang Chemical Co., Ltd.) at 25. Stir under the arm for 5 hours. Then, the activated carbon was removed by filtration using a filter paper, and a 1 Torr aqueous NaOH solution was added thereto, and the pH of the obtained aqueous solution was adjusted to 7 Å to prepare a neutralized filtrate. The protein concentration in this neutralized filtrate was determined. The protein concentration was 29 201107479. After dialysis and removal of the acrylamide contained in the filtrate by a semipermeable membrane (Spectra/Por molecular weight cutoff of 10 Torr), Amic〇n uiira_15 (Millpore's molecular weight cutoff 3 〇〇〇) was used. The concentration was 1 time, and the measurement was performed using a Protein Assay (manufactured by Bio-Rad Co., Ltd.). The amount of protein present in 1 kg of the obtained aqueous solution of acrylamide is less than mg. In the same manner as in Example 1, the foaming test of the aqueous solution of the acrylamide aqueous solution was carried out. As a result, the foaming of the aqueous acrylamide solution was 1 mm, which was a good result. [Reference Example 2] In the aqueous solution of acrylamide obtained by the same operation as in Reference Example 1, the protein concentration in 1 kg of the aqueous solution of acrylamide was 10 mg, and Comparatively, the cell treated material prepared by the same operation was used. The foaming test of the acrylamide aqueous solution was carried out in the same manner as in Example 1. As a result, in the case of the cell treated material which was not subjected to the acid treatment, the foaming of the aqueous acrylamide solution was 100 mm or more, and it was impossible to use the product. bad. [Reference Example 3] A 52 wt% aqueous solution of acrylamide was prepared using a 0.3 mM aqueous solution of NaOH and an acrylamide (purity: 99.9%) for electrophoresis manufactured by First Chemicals Co., Ltd. 'In this aqueous solution, 2 Å of acrylic acid was added. An aqueous solution was obtained to obtain an aqueous acrylamide solution having a pH adjusted to 7. In the same manner as in Example 1, a foaming test of an aqueous solution of acrylamide was carried out, and as a result, the foaming of the obtained aqueous solution of acrylamide was less than 10 mm.

30 201107479 幾乎未觀祭到,為非常良好的結果。 [實例9] 在藉由與實例1相同的操作而得的丙烯酿胺水溶液 中’進行與參考例1相㈤的利用活性炭的處王里(除去蛋白 質),除此以外,進行與實例丨相同的操作,而獲得丙烯醯 胺水溶液。 以與貫例1相同的方式,進行丙烯醯胺水溶液的發泡 試驗,結果是丙烯醯胺水溶液的發泡為1〇mm,而為良好 的結果。 [實例10] 在進行實例1、實例6、實例7、及實例8的MF過濾 時,評價過濾性。評價是藉由以下方式進行:使用Mmip〇re30 201107479 Almost unobserved, very good results. [Example 9] In the aqueous solution of acrylamide obtained by the same operation as in Example 1, 'the removal of the protein using the activated carbon in the phase (f) of Reference Example 1 was carried out, except that the same procedure as in Example 丨 was carried out. The operation was carried out while obtaining an aqueous solution of acrylamide. The foaming test of the aqueous acrylamide solution was carried out in the same manner as in Example 1. As a result, the foaming of the aqueous acrylamide solution was 1 mm, which was a good result. [Example 10] When the MF filtration of Example 1, Example 6, Example 7, and Example 8 was carried out, the filterability was evaluated. Evaluation is done by: using Mmip〇re

Express SHC 0.5/0.2UM(膜面積為 13.8 cm2),對在 0.5 MPa 的條件下過濾時的過濾量進行比較。將實例1中的過濾量 設為1時’實例6為7、實例7為15、實例8為50。 [參考例4] 在藉由與參考例1相同的操作而得的丙烯醯胺水溶液 中’以在丙烯醯胺水溶液的1 kg中所存在的蛋白質濃度為 10 mg的方式,添加藉由與比較例1相同的操作而製備的 菌體處理物。 以與實例1相同的方式,進行丙烯醯胺水溶液的發泡 試驗,結果是丙烯醯胺水溶液的發泡為100 mm以上,無 法製成製品使用而不良。 [實例11] 31 201107479一 [丙烯醯胺系聚合物的製造] 在上述實例及比較例中所得的丙烯醯胺水溶液中添加 水而製作濃度為20 wt%的丙烯醯胺水溶液。將此2〇 wt% 丙烯醯胺水溶液500 g加入至1 L聚乙烯容器中,一邊保 持為18°C—邊通氮氣而將溶液中的溶存氧氣除去,並立即 加入至發泡苯乙烯製的保溫用砌塊(block)中。另外,使 氮氣在聚乙烯容器中的溶液上面繼續流通,以使氧氣不溶 解在溶液中。 接著’將20〇xl〇_6 mpin (相對於丙烯醯胺的莫耳比) 的4,4’-偶氮雙(4-氰基戊酸鈉)、2〇〇xl〇-6 mpin的二曱基胺 基丙腈、及8〇xl〇_6 mpm的過硫酸銨分別溶解在少量的水 中,並依序快速地注入至1 L·的聚乙烯容器中。預先對該 些忒劑通氮氣,另外,在注入時及注入前後,亦在上述聚 乙烯容器中通少量氮氣,來防止氧氣混入。 ^ 若注入該些試劑’則發現在數分鐘的誘發期後,聚乙 婦合盗的内部溫度上升’因此停止氮氣供給。在保溫用砌 境中’―直在上述狀態下保持聚乙烯容器約100分鐘,結 ,聚乙烯容器的内部溫度達到約7(TC。因此,將聚乙烯容 裔自保溫用彻塊取出,在97°C的水中浸潰2小時再進行聚 _反應。然後浸潰在冷水中進行冷卻,而停止聚合反應。 <將以上述方式獲得的丙烯醯胺聚合物的含水凝膠自聚 乙缚奋裔中取出’分成小塊,利用絞肉器絞碎。將此絞碎 的丙歸酿胺聚合物的含水凝膠在loot:的熱風中乾燥2小Express SHC 0.5/0.2UM (membrane area 13.8 cm2) was compared for filtration at 0.5 MPa. When the amount of filtration in Example 1 was set to 1, 'Example 6 was 7, Example 7 was 15, and Example 8 was 50. [Reference Example 4] In the aqueous solution of acrylamide obtained by the same operation as in Reference Example 1, the ratio of the protein present in 1 kg of the aqueous solution of acrylamide was 10 mg, and the addition and comparison were carried out. The bacterial material preparation prepared in the same manner as in Example 1. The foaming test of the aqueous acrylamide solution was carried out in the same manner as in Example 1. As a result, the foaming of the aqueous acrylamide solution was 100 mm or more, which was unsuitable for use as a product. [Example 11] 31 201107479 - [Production of acrylamide-based polymer] Water was added to an aqueous solution of acrylamide obtained in the above examples and comparative examples to prepare a acrylamide aqueous solution having a concentration of 20% by weight. 500 g of this 2 wt% acrylamide aqueous solution was added to a 1 L polyethylene container while maintaining the temperature at 18 ° C - the dissolved oxygen in the solution was removed by nitrogen gas, and immediately added to the foamed styrene. Insulation block. Further, nitrogen gas was allowed to flow over the solution in the polyethylene container so that oxygen did not dissolve in the solution. Then '20〇xl〇_6 mpin (relative to the molar ratio of acrylamide) 4,4'-azobis(4-cyanovalerate), 2〇〇xl〇-6 mpin The mercaptoaminopropionitrile and the ammonium persulfate of 8〇xl〇_6 mpm were respectively dissolved in a small amount of water, and sequentially injected into a 1 L·polyethylene container. Nitrogen gas was previously supplied to the tanning agents, and a small amount of nitrogen gas was introduced into the polyethylene container at the time of injection and before and after the injection to prevent oxygen from entering. ^ If these reagents are injected, it is found that the internal temperature of the polyethylene thief rises after a few minutes of induction period, thus stopping the supply of nitrogen. In the insulation environment, the polyethylene container is kept in the above state for about 100 minutes, and the internal temperature of the polyethylene container reaches about 7 (TC. Therefore, the polyethylene is removed from the insulation by the block. The poly-reaction was carried out by immersing in water at 97 ° C for 2 hours, and then immersed in cold water for cooling, and the polymerization reaction was stopped. < The aqueous gel of the acrylamide polymer obtained in the above manner was self-polymerized. Take out the 'five pieces' and divide them into small pieces and grind them with a meat grinder. Dry the hydrogel of the ground chopped amine resin in a hot air of loot: 2 small

32 S 201107479 :、接著,利用高速旋轉刀粉碎器進行粉碎而獲得乾燥粉 末狀的丙烯醯胺聚合物。 么將所得的乾燥粉末狀的丙烯醯胺聚合物過篩,分取32 入 也)42網目的聚合物。藉由後述的丙稀臨胺聚 s物的4驗法來評價此分取的丙稀醯胺聚合物。評價結 示於表2。 ' [丙稀酿胺聚合物的試驗法] 、上述聚合物樣品製造時的聚合速度是藉由到達最高溫 度為止的時間來評價。另外,按以下方法來評價上述所得 的聚合物樣品的水溶性及標準黏度。 水溶性:水溶性是在1 L燒杯中加入水600 mL,以規 定形狀的擾拌翼在25°C下攪拌,並添加聚合物樣品0.66 g (聚丙烯醯胺純分〇·6 g),以4〇〇 rpm攪拌2小時,藉由 150網目的金網對所得的溶液進行過濾,根據不溶解成分 的多少及過濾性,來判斷水溶性。即,將完全溶解的溶液 設為AA ’將接近完全溶解的溶液設為bb,將有不溶解成 分但可將其過濾分離的溶液設為CC,將濾液通過緩慢、 且不溶解成分事實上無法過濾的溶液設為DD。 標準黏度:藉由上述水溶性試驗而得的濾液是濃度為 0.1 wt%的聚合物水溶液,在其中添加相當於1 Μ濃度的氯 化鈉,藉由BL型黏度計使用BL適配器,在25°C、轉子 轉速60 rpm下測定黏度(標準黏度)。藉由此種方法而得 的標準黏度一慣作為與分子量具有相關關係的值。 an- 33 201107479 [表2] Ί------ 贫白質濃度 Cmg/kg . aam 水逵液) 發泡性 (發泡高度) 聚合速度 (相對值) 聚合物的溶 解性 聚合物水溶灰' 的黏度 (mPa · s) 賁例1 實例2 10 未觀察到 1 AA 5.5 ' 10 未觀察到 1 AA 5.5 ^' 貫例3 10 未觀察到 1 AA 5.5 ~~~' 貫例4 8 未觀察到 1 AA 5.5 貫例5 1〇 未觀察到 1 AA 5.5〜 夏例6 '5~~~ .未觀察到 1 AA 5.5 H列/ ^9~~~~~ 未觀察到 1 AA 5.5 ' 貝,J δ 實例9 比較例1 9 ----- 未觀察到 1 AA 53 _ 小吃色 1 10 mm 1 AA 5.5 參考例1 OU —---- 100 mm以上 - - - 參考例2 參考例^ 小於0.1 10 mm 1 AA 5.5 ' __10 小於0.1 100 mm以上 去链家fil 1 A Λ ---. 不傳L带玉J 1 AA 5.5 ' ------ 寄存編號 PERM BP-5785 限定發Γ已以較佳實施例揭露如上,然其並非用以 和範圍;,=者,在不脫離本發明之精神 範圍當視後^二:^=飾定者=本發明之保護 【圖式簡單說明】 益 【主要元件符號說明】 3432 S 201107479 : Next, pulverization was carried out by a high-speed rotary knife pulverizer to obtain a dry powdery acrylamide polymer. The obtained dry powdery acrylamide polymer was sieved and the polymer of 42 mesh was obtained. This fractionated acetamide polymer was evaluated by the 4-test of propylene-based polyamines described later. The evaluation is shown in Table 2. 'Test method for acrylamide polymer> The polymerization rate at the time of production of the above polymer sample was evaluated by the time until the highest temperature was reached. Further, the water solubility and standard viscosity of the polymer sample obtained above were evaluated in the following manner. Water-soluble: Water-soluble is 600 mL of water in a 1 L beaker, stirred at 25 ° C in a prescribed shape, and a polymer sample of 0.66 g (polyacrylamide pure bifurcation · 6 g) is added. After stirring at 4 rpm for 2 hours, the obtained solution was filtered through a 150-mesh gold net, and water solubility was judged based on the amount of insoluble components and the filterability. That is, the completely dissolved solution is set to AA', and the solution which is nearly completely dissolved is set to bb, and the solution which has insoluble components but can be separated by filtration is set to CC, and the filtrate is passed through the slow, insoluble component. The filtered solution was set to DD. Standard viscosity: The filtrate obtained by the above water solubility test is an aqueous solution of a polymer having a concentration of 0.1 wt%, to which sodium chloride equivalent to 1 Torr is added, and a BL adapter is used at 25° by a BL type viscometer. C. The viscosity (standard viscosity) was measured at a rotor speed of 60 rpm. The standard viscosity obtained by this method is used as a value having a correlation with the molecular weight. An- 33 201107479 [Table 2] Ί------ Lean white matter concentration Cmg/kg . aam Water sputum) Foaming (foaming height) Polymerization speed (relative value) Polymer soluble polymer water soluble ash ' Viscosity (mPa · s) Example 1 Example 2 10 No observed 1 AA 5.5 ' 10 No observed 1 AA 5.5 ^' Example 3 10 No observed 1 AA 5.5 ~~~' Example 4 8 Unobserved 1 AA 5.5 Example 5 1〇 No observed 1 AA 5.5~ Summer Example 6 '5~~~ . No observed 1 AA 5.5 H column / ^9~~~~~ No 1 AA 5.5 'Bei was observed. J δ Example 9 Comparative Example 1 9 ----- No observed 1 AA 53 _ Snack color 1 10 mm 1 AA 5.5 Reference example 1 OU —---- 100 mm or more - - - Reference example 2 Reference example ^ Less than 0.1 10 mm 1 AA 5.5 ' __10 Less than 0.1 100 mm or more to the chain fil 1 A Λ ---. Not pass L belt jade J 1 AA 5.5 ' ------ Registration number PERM BP-5785 Limited hair has been The preferred embodiments are disclosed above, but they are not intended to be used in the scope of the present invention. The present invention is not limited to the scope of the present invention. [Main component symbol description] 34

Claims (1)

201107479f 七、申請專利範圍: 1. 一種菌體處理物的製造方法,關體處理物 離腈水合__處理物,且該菌體處理物的製造方法包 括: ⑴製作產生腈水合酶的微生物的㈣破碎物的步驟; (2) 對該菌體破碎物進行酸處理的步驟; (3) 將上述步驟(2)的酸處理時所生成的 去的步驟;以及 于' ⑷對㈣上述步驟⑴的菌體破碎物進行驗處理 的步驟。 2. 如申請專利範㈣1項所述之菌體處理物的製造方 法,其中上述步驟(2)中所使用的酸為弱酸。 、3.如申請專利範圍第2項所述之菌體處理物的製造方 法’其中上述獅為選自丙烯酸、乙酸、及雜中的至少 1種0 、4.如申請專利範圍第1項所述之菌體處理物的製造方 法’其中在上述步驟⑷的喊理後再·樹脂或助滤劑 的至少任一種進行後處理。 5·如申請專利範圍第4項所述之菌體處理物的製造方 法,其中上述助濾劑為矽藻土。 6. 如申叫專利範圍第5項所述之菌體處理物的製造方 法’其中上述矽藻土為Celite。 7. 如申叫專利範圍第4項所述之菌體處理物的製造方 法,其中上述樹脂為離子交換樹脂。 8. 如申請專利範圍第1項所述之菌體處理物的製造方 35 201107479 法,其中產生腈水合酶的微生物為在任意的宿主中高度表 現由此微生物選殖的腈水合酶基因的形質轉換體;以及利 用重組DNA技術使此腈水合酶的構成胺基酸的1個或2 個以上藉由其他胺基酸置換、缺失、削除或插入,從而表 現耐醯胺化合物性或耐腈化合物性、耐溫度性進一步提昇 的變異型腈水合酶的形質轉換體。 9. 如申請專利範圍第1項所述之製造方法’其中產生 腈水合酶的微生物為屬於假諾卡氏菌(Pseud〇n〇cardia)屬 的微生物。 10. —種(曱基)丙烯醯胺的製造方法,其是利用藉由如 申請專利範圍第1項至第9項中任一項所述之製造方法而 得的菌體處理物,由(甲基)丙烯腈製造(曱基)丙烯醯胺。 11. 一種(甲基)丙烯醯胺,其由如申請專利範圍第10 項所述的製造方法而得。 12. —種(甲基)丙烯醯胺水溶液,其由如申請專利範圍 第10項所述之製造方法而得,且該(甲基)丙烯醯胺水溶液 在每1 L的40 wt%〜80 wt%的丙烯醯胺或10 wt%〜4〇 wt°/〇的曱基丙烯酿胺、及水的溶液申包含〇j mg〜5〇 的蛋白質。 13. —種(甲基)丙烯醯胺系聚合物的製造方法,其是使 用如申請專利範圍第11項所述之(曱基)丙烯醯胺、或如申 請專利範圍第12項所述之(曱基)丙烯醯胺水溶液而製造 (曱基)丙烯醯胺系聚合物。201107479f VII. Patent application scope: 1. A method for manufacturing a bacterial body treatment product, wherein the biological treatment product is hydrated from the nitrile __ treatment, and the preparation method of the bacterial treatment material comprises: (1) preparing a microorganism producing nitrile hydratase (4) a step of crushing the object; (2) a step of acid-treating the broken material of the cell; (3) a step of removing the acid obtained by the step (2); and a step (1) of (4) The step of performing the treatment of the broken body of the bacteria. 2. The method for producing a bacterial material treated product according to the above paragraph (4), wherein the acid used in the above step (2) is a weak acid. 3. The method for producing a bacterial cell treated product according to the second aspect of the invention, wherein the lion is at least one selected from the group consisting of acrylic acid, acetic acid, and miscellaneous. The method for producing a bacterial cell treated product is described in which at least one of the resin or the filter aid is post-treated after the above-mentioned step (4). The method for producing a bacterial cell treated material according to the fourth aspect of the invention, wherein the filter aid is diatomaceous earth. 6. The method for producing a bacterial cell treated product according to claim 5, wherein the diatomaceous earth is Celite. 7. The method for producing a bacterial body treated product according to the fourth aspect of the invention, wherein the resin is an ion exchange resin. 8. The method of producing a cell treated product according to claim 1, wherein the microorganism producing a nitrile hydratase is a form of a nitrile hydratase gene highly expressed by the microorganism in any host. a transformant; and one or more of the constituent amino acids of the nitrile hydratase by a recombinant DNA technique, which are substituted, deleted, deleted or inserted by other amino acids, thereby exhibiting melamine-resistant compound or nitrile-resistant compound A shape-transformer of a variant nitrile hydratase which is further improved in temperature and temperature resistance. 9. The production method according to claim 1, wherein the microorganism in which the nitrile hydratase is produced is a microorganism belonging to the genus Pseud〇n〇cardia. A method for producing a bismuth (mercapto) acrylamide, which is obtained by using the method according to any one of the first to ninth aspects of the invention, wherein Methyl)acrylonitrile (mercapto) acrylamide. A (meth) acrylamide obtained by the production method according to claim 10 of the patent application. 12. An aqueous solution of (meth) acrylamide, which is obtained by the production method of claim 10, and the (meth)acrylamide aqueous solution is 40 wt% to 80 per 1 L. A solution of wt% acrylamide or 10 wt% to 4 〇 wt ° / hydrazine decyl acrylamide, and water contains 〇 j mg 〜 5 〇 protein. A method for producing a (meth) acrylamide-based polymer, which comprises using (mercapto) acrylamide as described in claim 11 or as claimed in claim 12 A (mercapto) acrylamide-based polymer is produced by a (hydrazino) acrylamide aqueous solution. 36 201107479 四、 指定代表圖: (一) 本案指定代表圖為:無 (二) 本代表圖之元件符號簡單說明: 無 五、 本案若有化學式時,請揭示最能顯示發明特徵 的化學式: 201107479 ί__________ 爲第99123033號中文說明書無劃線修正頁 修正日期"審_ 4正‘ _ . .. L_ 福充丨 t合物的品質優異的丙烯醯胺。 . 一為讓本發明之上述和其他目的、特徵和優點能更明顯 易懂,下文特舉較佳實施例,並配合所附圖式,作詳細說 明如下。 v β 【實施方式】 本發明中可用的產生腈水合酶的微生物可列舉屬於以 -下屬的微生物等:奴卡氏菌(Nocardia)屬、棒狀桿菌 〇 (Corynebacterium)屬' 桿狀菌(Bacillus)屬、嗜熱性桿 狀菌屬、偽單胞菌(pseudomonas)屬、微球菌㈤化觸沉⑽) 屬、以紫紅色(rhodochrous )種為代表的紅球菌 (Rh〇d〇C〇CCUS)屬、不動桿菌(Adnet〇bacter)屬、黃色 才干囷(Xanthobacter)屬、鍵徽菌(streptomyces )屬、根 瘤菌(Rhizobium )屬、克雷白氏菌(Klebsiella )屬、腸 桿菌(Enterobacter)屬、伊文氏桿菌(Erwinia)屬、產氣 單胞菌(Aeromonas)屬、檸檬酸桿菌(citr〇bacter)屬、 無色桿菌(Achromobacter)屬、農桿菌(Agrobacterium) D 屬或以嗜熱(thermophila )種為代表的假諾卡氏菌 (Pseudonocardia)屬、無芽孢桿菌(Bacteridium)屬、短 桿菌(Brevibacterium)屬。另外亦可列舉:在任意的宿主 中高度表現由該些微生物選殖的腈水合酶基因的形質轉換 體;及利用重組DNA技術使此腈水合酶的構成胺基酸的1 個或2個以上藉由其他胺基酸置換、缺失、削除或插入, 而表現耐醯胺化合物性或耐腈化合物性、耐溫度性進一步 提昇的變異型腈水合酶的形質轉換體等。 201107479 修正日期:99年Π月8日 爲第99123033號中文說明書無畫卩線修正頁 另外,此處所謂的任意的宿主(h〇st),如後述的實例 般,可列舉大腸菌(Escherichia coli)作為代表例,但並不 特別限定於大腸菌,亦可包括枯草桿@ (]Badllussu隨s) 等桿狀菌屬菌,酵母或放線菌等其他微生物菌株。如上述 般的菌的例子可列舉:MT_10822 (此菌株是在1996年2 月7日以寄存編號FERM Bp_5785,基於與專利程序上微 ,物寄存的國際承認相關的布達佩斯條約而寄存在茨城縣 築波市東1 T目1番3號的通商產業紅業技術院生命二 學工業技術研究所(現茨城縣築波市東築波中心 中央第6獨立行政法人產業技術綜合研究所專利生: 寄存中心))。 該些微生物巾,就具有高潍、高敎性的腈水合酶的 方面而言,較佳為屬於假諾卡氏菌(Pseud〇n〇cardia 政生物、及在任意的宿主中高度表現由此微生物選殖的 合酶基_形㈣健、絲現變異歸水合_形 體。另外,上述形質轉賴就進—步提高腈水合酶、 性、每個菌體的活性更高的方面而言,較佳。 ·' 另外,在微生物内可而度表現腈水合酶的紫紅色 菌(Rhodococcus rhodochrcms ) Μ、在任意的宿主、古碎 J現由此微生物選殖的腈水合酶基因的形質轉換體亦= 較佳。 J ^ 上述產生腈水合酶的微生物的菌體可藉由分 學、生物王程、基仏簡領域中公知的—般方法而物 例如可藉由以下方式而製備:在❿培養基、_培養基等 201107479 爲第99123033號中文說明書無劃線纟 Ξ頁 修正日期:99年II月8日 佳為2小時〜48小時的範圍。 f應形式並無特定,可為批:欠式、半批次式,亦 二私^續式的反應。另外,反應器可為斜床、固定床、 ^床寻的任意—種。另外,可將多㈣式的反應器加以 組合。 Ο 觸媒的使用量亦依存於反應條件,通常按此微生物乾 =體質量換算,觸媒的使用量相對於反應液的質量= 鹏〜5_鹏,較佳為5G ppm〜3_〇 ppm。 一另外,水合反應通常在常墨或常壓附近進行,為了提 南腈化合物在水性制巾的溶解度,亦可在加壓下進行。 另外,關於反應溫度,若為水性制的冰馳上,則並益 特別限制,通常較佳為S叱〜坑的範圍内進行,更^ 為10°c〜4(TC的範圍。另外,亦可在產物於反應液中結晶 (crystallize)的漿料(slurry)狀態下進行反應。另外, 上述水合反應時的反應液的pH值只要可維持猜水合酶活 ❹ 性、,則並無特別限制,較佳為pH值為6〜1〇的範圍,更 佳為pH值為7〜9的範圍。 藉由上述操作,可獲得每1 L的水溶液中包含蛋白質 較佳為0.1 mg〜50 mg、更佳為5 mg〜2〇 mg的(甲 醯胺水溶液。 种 另外,本發明中,蛋白質濃度是使用作為標準的隨附 的牛血清白蛋白(albumin),藉由PlOteinAss 公司製造)而求得。 d 即便包含上述範圍的此種蛋白質,亦未觀察到所得的 17 201107479 ^正臼期:99年II月8曰 爲第99123033號中文說明書無劃線修正頁 (甲基)丙制胺水溶液的發泡,操作性優異 基)丙烯醒胺而得的(甲基)丙稀酿胺系聚合物為高品質此(甲 B士,^述(甲基)丙烯酿胺水溶液中烯酿胺 守車乂<土為§有4〇加0/〇〜8〇加%的丙湘鱼胺,為甲 醯胺時嘯佳為含有1()痛〜4_简甲基丙婦酿^。 本發明的(甲基)丙烯醯胺系聚合物可藉由以下方式製 造:將以上述方式而得的(甲基)丙烯醯胺進行均聚合二^36 201107479 IV. Designated representative map: (1) The representative representative of the case is: No (2) The symbol of the symbol of the representative figure is simple: No. 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: 201107479 ί__________ For the Chinese manual No. 99123033, there is no sizing correction page correction date " _ _ 4 positive ' _ . . . L_ Fu 丨 丨 合物 合物 合物 合物 合物 合物 合物 。 。 。 。 。 。 The above and other objects, features, and advantages of the present invention will become more fully understood from v β [Embodiment] The nitrile hydratase-producing microorganism which can be used in the present invention may be exemplified by microorganisms belonging to the subordinates, such as the genus Nocardia, and the genus Corynebacterium, Bacillus. ), genus, thermophilic bacillus, pseudomonas (genus pseudomonas), micrococcal (five) stagnation (10)) genus, rhodococcus (Rho〇ochrous) species represented by Rhodococcus (Rh〇d〇C〇CCUS) Genus, Adnet〇bacter, Xanthobacter, streptomyces, Rhizobium, Klebsiella, Enterobacter , genus Erwinia, genus Aeromonas, citr〇bacter, Achromobacter, Agrobacterium D genus or thermophila The species is represented by the genus Pseudonocardia, the genus Bacteridium, and the genus Brevibacterium. Further, a shape-converting substance which highly expresses a nitrile hydratase gene selected from the microorganisms in any host; and one or more amino acids constituting the nitrile hydratase by recombinant DNA technology may be mentioned. A shape-transformer of a variant nitrile hydratase which exhibits resistance to guanamine compounding or nitrile-resistance and temperature resistance is further improved by substitution, deletion, removal or insertion of other amino acids. 201107479 Date of revision: 99th, the 8th of the next month, the 99th, the Chinese manual, the no-line correction page. In addition, the arbitrary host (h〇st) here, as the example described later, can be cited as Escherichia coli. As a representative example, it is not particularly limited to coliform bacteria, and may include other microbial strains such as a genus of the genus Bacillus, such as a bacterium, a yeast, or an actinomycete. An example of the above-mentioned bacteria is: MT_10822 (This strain was deposited in Ibaraki Prefecture on February 7, 1996 under the registration number FERM Bp_5785, based on the Budapest Treaty relating to the international recognition of the micro-material registration of the patent procedure. Boss City, 1st, 1st, 1st, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd, 3rd ). The microbial towel preferably has a high sorghum and high sulphur nitrile hydratase, and is preferably a Pseud〇n〇cardia genus, and is highly expressed in any host. The synthase base of microbial selection _ shape (four) health, silk is now variegated to hydrated _ shape. In addition, the above-mentioned morphological conversion is to improve nitrile hydratase, sex, and the activity of each cell is higher. Preferably, 'In addition, the Rhodococcus rhodochrcms can be expressed in the microorganisms, and the shape of the nitrile hydratase gene in the host, the ancient J. Also preferred is J ^ The above-mentioned microbial cell producing a nitrile hydratase-producing microorganism can be prepared, for example, by a method known in the fields of branching, biological process, and hydrazine, for example, by the following method: Medium, _ medium, etc. 201107479 is the 99123033 Chinese manual without a stencil sheet Revision date: 99 years, February 8th, the best range of 2 hours to 48 hours. f should be no specific form, can be batch: owed Half batch, also two ^Continuous reaction. In addition, the reactor can be any of a slant bed, a fixed bed, or a bed. In addition, multiple (four) reactors can be combined. Ο The amount of catalyst used depends on the reaction conditions. Usually, according to the microbial dry mass ratio, the amount of the catalyst used is relative to the mass of the reaction solution = 鹏~5_鹏, preferably 5G ppm~3_〇ppm. In addition, the hydration reaction is usually in the usual ink or It is carried out in the vicinity of normal pressure, and the solubility of the nitrile compound in the water-based towel may be carried out under pressure. Further, the reaction temperature is particularly limited if it is an ice-based method, and it is usually preferred. It is carried out in the range of S叱~pit, and is further in the range of 10 ° c to 4 (TC). Alternatively, the reaction may be carried out in a slurry state in which the product is crystallized in the reaction liquid. The pH of the reaction liquid in the hydration reaction is not particularly limited as long as the activity of the hydration enzyme is maintained, and it is preferably in the range of pH 6 to 1 Torr, more preferably in the range of 7 to 9 pH. By the above operation, it is possible to obtain an egg per 1 L of the aqueous solution. The white matter is preferably 0.1 mg to 50 mg, more preferably 5 mg to 2 mg (the aqueous solution of methotrexate. In addition, in the present invention, the protein concentration is used as a standard accompanying bovine serum albumin (albumin). , obtained by the company PlOteinAss.) d Even if the protein of the above range is included, no result is observed. 17 201107479 ^正臼期:99年二月8曰为99123033号The (meth) propylamine aqueous solution is foamed, and the operability is excellent.) The (meth) acrylamide-based polymer obtained by acrylamide is high-quality (A, B, Methyl) Acrylic amine in the aqueous solution of enamines in the amphibious sputum < soil for § has 4 〇 plus 0 / 〇 ~ 8 〇 plus % of cimelamine, for carbamide when Xiaojiao contains 1 () pain ~ 4_ Jane methyl propylene fondue ^. The (meth) acrylamide polymer of the present invention can be produced by homopolymerizing (meth) acrylamide obtained in the above manner. 將(曱基)丙烯醯胺與能和(甲基)丙稀醯胺共聚合的^少二 種不飽和單體進行共聚合。 能和(甲基)丙烯醯胺共聚合的不飽和單體可列舉: 丙烯酸、甲基丙烯酸、衣康酸、馬來酸、富馬酸等不 飽和叛酸及該些羧酸的鹽; 乙烯磺酸、苯乙烯磺酸、丙烯醯胺曱基丙磺酸及該些 酸的鹽; 曱基丙烯酸·Ν,Ν-二曱基胺基乙醋(N, N-dimethylamino ethyl methacrylate )、甲基丙烯酸-Ν,Ν·二乙基胺基乙酯、丙The (fluorenyl) acrylamide is copolymerized with two less unsaturated monomers copolymerizable with (meth) acrylamide. Examples of the unsaturated monomer copolymerizable with (meth) acrylamide: unsaturated unsaturated acid such as acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, and salts of the carboxylic acids; Sulfonic acid, styrene sulfonic acid, acrylamidopropane sulfonic acid and salts of the same; dimethyl acrylate, N, N-dimethylamino ethyl methacrylate, methyl Acrylic acid - hydrazine, hydrazine diethylaminoethyl ester, C 烯酸-Ν,Ν-二曱基胺基乙酯等(甲基)丙烯酸的烷基胺基烷基 西旨’或者該些g旨的四級銨衍生物; N,N-二甲基胺基丙基甲基丙烯醯胺、N,N_二曱基胺基 丙基丙烯醯胺等N,N-二烷基胺基烷基(甲基)丙烯醯胺、或 該些(甲基)丙烯醯胺的四級銨衍生物; 丙酮丙烯醯胺、N,N-二曱基丙烯醯胺、Ν,Ν-二甲基甲 基丙烯醯胺、Ν-乙基曱基丙烯醯胺、N-乙基丙烯醯胺、Ν,Ν-二乙基丙烯醯胺、Ν_丙基丙烯醯胺等親水性丙烯醯胺; 18 201107479 修正日期:99年11月8日 爲第99123033號中文說明書無襄(線修正頁 另外,聚合時的水溶液的pH值亦無特別限定, 要可調整pH值而進行聚合。此時可使用的阳值調$ 列舉:氫氧化納、氫氧化卸、氨等驗;鱗酸、石荒酸、 等無機酸;曱酸、乙酸等有機酸等。 孤 、藉由本發明而得的聚合物的分子量並無特別限制,通 常為10萬〜5_萬的範圍’較佳為5〇萬〜纖萬的範圍。An alkylaminoalkyl group of (meth)acrylic acid such as an enoic acid-hydrazine, anthracene-didecylaminoethyl ester or a quaternary ammonium derivative of the same; N,N-dimethylamine N,N-dialkylaminoalkyl(meth)acrylamide such as propyl methacrylamide or N,N-didecylaminopropyl acrylamide, or these (methyl) Tetra-ammonium derivatives of acrylamide; acetone acrylamide, N,N-dimercapto acrylamide, hydrazine, hydrazine-dimethyl methacrylamide, hydrazine-ethyl decyl acrylamide, N - Hydrophilic acrylamide such as ethyl acrylamide, hydrazine, hydrazine-diethyl acrylamide, hydrazine-propyl acrylamide; 18 201107479 Revision date: November 8, 1999 is No. 99123033 Chinese manual襄 (Line correction page In addition, the pH of the aqueous solution during polymerization is not particularly limited, and it is necessary to adjust the pH to carry out polymerization. The positive value can be used at this time: enumerated: sodium hydroxide, hydroxide, ammonia, etc. ; sulphuric acid, sulphuric acid, and other inorganic acids; organic acids such as citric acid, acetic acid, etc. The molecular weight of the polymer obtained by the present invention is not particularly limited, and is usually 100,000 to 50,000. Range '5〇 preferably in a range of ten thousand million to fiber. 日,以上述方式而得的本發明的(甲基)丙烯醯胺系聚合物 疋兼具水溶性與高分子量的聚合物,且色調優異,可適合 用作凝聚劑、製紙用添加劑、石油回收劑等。 >口 實例 以下,根據實例對本發明進行更具體地說明,但本發 明不文該些實例限定。以下,只要無特別說明,〇/ 為質量基準。 [丙稀酿胺、甲基丙烯酿胺的分析] 各貫例及比較例、參考例中的高效液相層析法 (HPLC ’ high performance liquid chromatography )分析是 ◎使用=本分光製造的Finepak SIL C18_5 (25〇χ4 6 φ讓) 作為管柱,使用包含4v〇1%(體積百分比)的乙腈的i〇mM 水溶液作為展開液。另外,丙浠醯胺、曱基丙烯醯胺 藉由220 nm的吸光度進行檢測。 [製造例1] [菌體的製備] 依據日本專利特開2001-340091號的實例丨所記載的 方法,以曰本專利特開平09-275978中所得的pPT-DBl質 21 201107479 爲第99123033號中文翻書無劃線修正頁修正日期:99年u月8日 體DNA為模板,而取得日本專利特開平〇9_275978的實例 1表3所記載的n〇.3選殖菌體。具有pPT_DBl質體的大腸 菌是MT-10822株(寄存編號FERMBP-5785 ),如上所述 寄存在專利生物寄存中心。在經高壓蒸氣滅菌的包含〇1 g/L的FeS〇4、及〇.〇5 g/L的CoCl2的LB培養基中以達到 0.1 mg/L的方式添加安比西林(ampiciilin)。製作預培養 所用的培養基200ml,於此培養基中植菌—白金耳的:述 的No.3選殖菌體,在33°C的溫度下進行預培養。藉由濁 度測定法以把握預培養時的菌體的增殖量,在66〇 的 吸光度為3.0〜6.0的範圍的時刻結束預培養。將預培養所 得的培養液植菌於經高壓蒸氣滅菌過的表丨所示的正弋與 養時所用的培養基5 L巾,在33t:的溫度下—邊^、1〇 = 將空氣向培養液内通氣一邊進行攪拌,進行48小時正 養而獲得培養液(細胞懸浮液)。另外,自正气典養的土立 開始起監視培養液的pH值,在pH值為7·45二上時声= 30分鐘添加15 ml的5〇〇 g/L的葡萄糖。 tmz ----- 55~Τε)ΪΛ~~---- 聚蛋白脒(polypept〇ne) 7Ό —____ FeS04 · 7H20 ' nno"------ CoCl2 · 6H20 005*~—〜--- ~~~ 細W2SO4 ' ' ~~'~~ L5 --- MgS04 · 7H20 Z0 --- KH^ ----- Σο~ —-- K-2HP〇4 ADEKA NOL ---- 22 201107479 爲第99123033號中文說明書無劃線修正頁 修正日期:99年U月§日 [實例1] [由菌體製備包含游離的腈水合酶的菌體處理物] (利用均質器破碎菌體) 使用S ANWA ENGINEERING股份有限公司製造的均 質器1150,在溫度15。〇破碎壓力5〇]\/〇^、破碎日"夺間1〇〇 分鐘的條件下,將上述製造例丨中製備的培養液5 l所含 的菌體破碎,而製作使菌體所含的腈水合酶游離在溶液^ 的破碎溶液。 〜 ^ (熱處理) 將上述破碎溶液移至10L的玻璃燒杯中,一邊將破碎 溶液充分攪拌,一邊將玻璃燒杯浸潰在5〇t:的水浴恆溫槽 中。在破碎溶液的液溫達到50〇c後再繼續浸潰15分鐘: 然後取出燒杯在空氣中冷卻。 刀里 (利用酸析出雜質) 在充分攪拌的上述熱處理後的破碎溶液中,緩慢添加 2 Μ乙酸水溶液,直至溶液的pH值達到5 〇為止,^外, 〇 將此溶液攪拌3小時而使雜質析出。 (藉由離心分離除去破碎物等) 使用離心機(日立工機股份有限公司製造:cr22(j), f 5C 8000 rpm、15分鐘的條件下,將上述利用酸進行 破碎液進行離崎離,將藉由添加酸而析出的雜質 等除去’而獲得離心上清液。 (離心上清液的中和) 在充分擾拌的上述離心上清液中緩慢添加丄Μ的 23 201107479 修正日期:"年11月8日 爲第99Π3033號中文說明書無劃線修正頁 NaOH直至溶液的pH值達到7.0為止,而將離心上'.主、广中 和0 另外’在不實施此中和的情況下,由於雜質的析出而 無法進行後一步驟的MF過濾。 ' (中和液的MF過濾) 使用Poul公司製造的suporlife450 (DFC膠囊型),在〇 5 MPa的條件下,將上述中和的離心上清液過據。 ’ (過濾液的濃縮)In the above-mentioned manner, the (meth)acrylamide-based polymer of the present invention has a water-soluble and high molecular weight polymer and has excellent color tone, and can be suitably used as a coagulant, an additive for papermaking, and oil recovery. Agents, etc. > Port Example Hereinafter, the present invention will be more specifically described based on examples, but the present invention is not limited by the examples. Unless otherwise specified, 〇/ is the quality standard. [Analysis of acrylamide and methacrylamide] The HPLC 'high performance liquid chromatography' analysis in each of the examples and comparative examples and reference examples is ◎Finepak SIL manufactured using the spectrometer C18_5 (25〇χ4 6 φ let) As a column, an aqueous solution of i〇mM containing 4v〇1% (by volume) of acetonitrile was used as the developing solution. In addition, acrylamide and mercapto acrylamide were detected by absorbance at 220 nm. [Production Example 1] [Preparation of the cells] According to the method described in the example of JP-A-2001-340091, the pPT-DB1 quality 21 201107479 obtained in Japanese Patent Laid-Open No. 09-275978 is No. 99123033 The Chinese version of the book has no scribe line correction date. The date of the correction of the date: 99 years, the date of the month, the body DNA is the template, and the n〇.3 bacterium is described in Table 3 of Example 1 of Japanese Patent Laid-Open Publication No. 9_275978. The Escherichia coli having the pPT_DBl plastid is the MT-10822 strain (registered number FERMBP-5785), which is deposited in the patent bio-consignation center as described above. Ampicillin was added in an autoclaved LB medium containing g1 g/L of FeS〇4 and 〇.〇5 g/L of CoCl2 to achieve 0.1 mg/L. 200 ml of the medium used for the pre-culture was prepared, and the No. 3-selected cells of the bacterium, Platinum ear, described in the medium, were precultured at a temperature of 33 °C. The turbidity measurement method was used to grasp the amount of growth of the cells at the time of preculture, and the preculture was terminated at the time when the absorbance at 66 Torr was in the range of 3.0 to 6.0. The culture solution obtained by the pre-culture is sterilized in a medium of 5 liters of the medium used for the sputum and the cultivating time indicated by the autoclave sterilized at a temperature of 33 t: -1, 1 〇 = air is cultured The mixture was stirred while being ventilated in the liquid, and cultured for 48 hours to obtain a culture solution (cell suspension). In addition, the pH of the culture solution was monitored from the beginning of the normal gas culture, and 15 ml of 5 g/L glucose was added for 30 minutes at a pH of 7.45. Tmz ----- 55~Τε)ΪΛ~~---- Polypept〇ne 7Ό —____ FeS04 · 7H20 ' nno"------ CoCl2 · 6H20 005*~-~-- - ~~~ Fine W2SO4 ' ' ~~'~~ L5 --- MgS04 · 7H20 Z0 --- KH^ ----- Σο~ —-- K-2HP〇4 ADEKA NOL ---- 22 201107479 No. 99123033 Chinese manual without scribe correction page Revision date: 99 years U month § day [Example 1] [Preparation of bacterial cells containing free nitrile hydratase from cells] (Using a homogenizer to break the cells) Using S The homogenizer 1150 manufactured by ANWA ENGINEERING Co., Ltd. is at a temperature of 15. 〇 〇 压力 压力 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 The nitrile hydratase contained in the solution is dissolved in a solution of the solution. ~ ^ (Heat treatment) The above-mentioned crushed solution was transferred to a 10 L glass beaker, and while the crushed solution was thoroughly stirred, the glass beaker was immersed in a water bath of 5 〇t:. After the liquid temperature of the crushed solution reached 50 〇c, the dipping was continued for another 15 minutes: Then the beaker was taken out and cooled in the air. In the knives (precipitating impurities by acid), a 2 Μ acetic acid aqueous solution is slowly added to the crushed solution after the above-mentioned heat treatment which is sufficiently stirred until the pH of the solution reaches 5 ,, and the solution is stirred for 3 hours to make impurities. Precipitate. (Removal of the crushed material by centrifugation, etc.) Using a centrifuge (manufactured by Hitachi Koki Co., Ltd.: cr22(j), f 5C 8000 rpm, for 15 minutes, the above-mentioned crushed liquid by acid is removed. Centrifugal supernatant was obtained by removing impurities such as precipitated by adding acid. (Neutralization of Centrifugal supernatant) Slow addition of strontium in the above-mentioned centrifugation supernatant which was sufficiently disturbed 23 201107479 Revision date: &quot On November 8th, the Chinese manual No. 99Π3033 has no scribe line correction page NaOH until the pH value of the solution reaches 7.0, and will be centrifuged on '.Main, wide and 0 other' without performing this neutralization. MF filtration in the latter step was not possible due to the precipitation of impurities. ' (MF filtration of neutralizing solution) The above-mentioned neutralization centrifugation was carried out under the conditions of 〇 5 MPa using suporlife450 (DFC capsule type) manufactured by Poul Co., Ltd. The supernatant was passed. ' (Concentration of filtrate) 使用旭化成公司製造的Pencil型中空絲膜 AHP-0013,在平均壓力(U MPa、循環速度丄5 mm/sec的 條件下’進行5倍濃縮而獲得菌體處理物。 (蛋白質濃度的測定) 菌體處理物的蛋白質濃度是使用Pr〇tein ASSay (Bio-Rad公司製造)進行測定。標準是使用隨附的牛血 清白蛋白。測定結果是菌體處理物中的蛋白質濃度為5〇 mg/ml。Using a Pencil-type hollow fiber membrane AHP-0013 manufactured by Asahi Kasei Co., Ltd., the cells were treated with an average pressure (U MPa, cycle speed 丄 5 mm/sec) to obtain a bacterial body treatment. (Measurement of protein concentration) The protein concentration of the body treatment was measured using Pr〇tein ASSay (manufactured by Bio-Rad Co., Ltd.) The standard was to use the accompanying bovine serum albumin, and the result was that the protein concentration in the cell treatment was 5 〇 mg/ml. . [丙烯醯胺的製造] 準備具備攪拌器的1L玻璃製燒瓶作為第丨反應器, 準備内彳至為5 mm的Teflon (註冊商標)製管20 m作為第 二反應器。在第一反應器中預先投入4〇〇g水。 將藉由上述方法而製備的菌體處理物〇 〇3 wt%懸浮於 〇·3 mM-NaOH水溶液中。一邊對此懸浮液與丙烯腈進行攪 摔’一邊分別以49 g/h、31 g/h的速度向第1反應器中連 續地進料。接著’以將第1反應器的液面水平保持固定的 24 201107479 倚弟;yyiz3033號中文專利範圍無晝[|線修正本 修正臼期__99年I】月8日 〇 〇 七、申請專利範圍: 1. 一種菌體處理物的製造方法,該菌體處理物包含離腈水合酶的菌體處理物,且該菌體處理物的製造方法包 括·〇)製作^生腈水合酶的微生物㈣體破碎物的步驟; (2)對該菌體破碎物進行酸處理的步驟; ⑶將上述步驟⑵的酸處理時所生成的不溶物除 去的步驟;以及 (4)對經過上述步驟(3)的菌體破碎物進行驗處理 的步驟。 2.如申請專利範圍第!項所述之菌體處理物的製造方 法,其中上述步驟(2)中所使用的酸為弱酸。、 、3.如申請專利範圍第2項所述之菌體處理物的製造方 法’其中上述弱酸為選自丙烯酸、6酸、及麟酸中的至少 1種。 4.如申叫專利範圍第旧所述之菌體處理物的製造方t其!在上述步驟(4)的鹼處理後再利用樹脂或助濾劑 的至少任一種進行後處理。 5甘:申請專利範圍第4項所述之菌體處理物的製造方 其中上述助濾劑為矽藻土。 匕如申請專利範圍第5項所述之菌體處理物的製造方 其中上述矽藻土為Ceiite。 7社如申請專利範圍第4項所述之菌體處理物的製造方 ,、中上述樹脂為離子交換樹脂。 8.如申請專利範圍第丨項所述之㈣處理物的製造方 法 法 法 35 201107479 爲第99123033號中文專利範圍無晝ii線修正本修正日期:99年丨】月S曰 法’其中產生腈水合酶的微生物為在任意的宿主中高度表 現由此微生物選殖的腈水合酶基因的形質轉換體;以及利 用重組DNA技術使此腈水合酶的構成胺基酸的1個威2 個以上藉由其他胺基酸置換、缺失、削除或插入,從而表 現耐醯胺化合物性或耐腈化合物性、耐溫度性進一步提并 的變異型腈水合酶的形質轉換體。 9.如申請專利範圍第1項所述之菌體處理物的製造方 法’其中產生腈水合酶的微生物為屬於假諾卡氏菌 (Pseudonocardia)屬的微生物。 10_ —種(曱基)丙烯醯胺的製造方法,其是利用藉由如 申請專利範圍第1項至第9項中任一項所述之菌體處理物 的製造方法而得的菌體處理物,由(甲基)丙烯腈製造(曱基) 丙烯醯胺、。 11. 一種(甲基)丙烯醯胺,其由如申請專利範圍第1〇 項所述的(甲基)丙烯醯胺的製造方法而得。 ^ I2. 一種(甲基)丙烯醯胺水溶液’其由如申請專利範圍 第10項所述之(甲基)丙烯醯胺的製造方法而得,且該(甲 丙烯醯胺水溶液在每i L的40 wt%〜80 wt%的丙烯醯 胺或10 wt %〜4 0 wt %的曱基丙烯醯胺、及水的溶液中包含 〇·1 mg〜50 mg的蛋白質。 3 13. —種(甲基)丙烯醯胺系聚合物的製造方法,i是使 用如申請專利範圍第η項所述之(甲基)丙烯酿胺、或如申 清專利範圍第12項所述之(曱基)丙烯雜水溶液而 (甲基)丙烯醯胺系聚合物。 、 36[Production of acrylamide] A 1 L glass flask equipped with a stirrer was prepared as a second reactor, and a tube of 20 mm of a Teflon (registered trademark) tube of 5 mm was prepared as a second reactor. 4 g of water was previously charged in the first reactor. The cell treatment 〇 3 wt% prepared by the above method was suspended in a 〇·3 mM-NaOH aqueous solution. While the suspension and the acrylonitrile were stirred off, the first reactor was continuously fed at a rate of 49 g/h and 31 g/h, respectively. Then 'to keep the level of the liquid level of the first reactor fixed 24 201107479 依弟; yyiz3033 Chinese patent scope is flawless [| line correction this revision period __99 year I] month 8 〇〇 seven, the scope of patent application A method for producing a bacterial cell treated product comprising a cell treated product of nitrile hydratase, and a method for producing the cell treated product, comprising: producing a microorganism capable of producing a nitrile hydratase (IV) a step of pulverizing the body; (2) a step of subjecting the cell body to acid treatment; (3) a step of removing the insoluble matter formed during the acid treatment of the above step (2); and (4) performing the above step (3) The step of performing the treatment of the broken body of the bacteria. 2. If you apply for a patent scope! The method for producing a bacterial body treatment according to the above aspect, wherein the acid used in the above step (2) is a weak acid. The method for producing a bacterial cell treated product according to the second aspect of the invention, wherein the weak acid is at least one selected from the group consisting of acrylic acid, acid 6 and linonic acid. 4. The manufacturer of the bacterial material treated as described in the patent application scope is called! After the alkali treatment in the above step (4), it is post-treated with at least one of a resin or a filter aid. 5: A method for producing a bacterial material treated product according to item 4 of the patent application, wherein the above-mentioned filter aid is diatomaceous earth. For example, the method for producing a bacterial material treated product according to claim 5, wherein the diatomaceous earth is Ceiite. The method for producing a bacterial material treated product according to the fourth aspect of the invention, wherein the resin is an ion exchange resin. 8. As described in the scope of application of the patent scope (4) Method of manufacturing processed materials 35 201107479 is the Chinese patent scope of No. 99123033 No revision ii line revision date: 99 years 丨] month S曰 method 'where nitrile is produced The hydratase-producing microorganism is a shape-transformer of a nitrile hydratase gene highly expressed by the microorganism in any host; and one or more of the ones of the amino acid constituting the nitrile hydratase by the recombinant DNA technique A shape-transformer of a variant nitrile hydratase which is substituted, deleted, deleted or inserted by other amino acids to exhibit further resistance to guanamine compound or nitrile-resistant compound and temperature resistance. 9. The method for producing a bacterial cell treated product according to claim 1, wherein the microorganism producing the nitrile hydratase is a microorganism belonging to the genus Pseudonocardia. A method for producing a bismuth (mercapto) acrylamide, which is obtained by a method for producing a bacterial cell treated product according to any one of claims 1 to 9 Manufactured from (meth)acrylonitrile (mercapto) acrylamide. A (meth) acrylamide obtained by the method for producing (meth) acrylamide as described in claim 1 of the patent application. ^ I2. An aqueous solution of (meth) acrylamide, which is obtained by the method for producing (meth) acrylamide as described in claim 10, and the aqueous solution of methacrylamide is in every i L 40 wt% to 80 wt% of acrylamide or 10 wt% to 40 wt% of decyl acrylamide, and water solution containing 〇·1 mg~50 mg of protein. A method for producing a methyl methacrylate-based polymer, i is a (meth)acrylamide as described in claim n, or a sulfhydryl group as described in claim 12 A propylene mixed aqueous solution and a (meth) acrylamide polymer.
TW099123033A 2009-07-13 2010-07-13 Fabrication method of microbial cell treated material TW201107479A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009164863 2009-07-13

Publications (1)

Publication Number Publication Date
TW201107479A true TW201107479A (en) 2011-03-01

Family

ID=43449334

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099123033A TW201107479A (en) 2009-07-13 2010-07-13 Fabrication method of microbial cell treated material

Country Status (3)

Country Link
JP (1) JP5430659B2 (en)
TW (1) TW201107479A (en)
WO (1) WO2011007725A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101736018B1 (en) 2012-02-28 2017-05-15 미쯔비시 케미컬 주식회사 Method for preserving enzyme
JPWO2016140045A1 (en) * 2015-03-02 2017-04-27 三菱レイヨン株式会社 Surfactant-containing amide compound aqueous solution
CN112522337B (en) * 2020-11-16 2023-02-17 广东宝莫生物化工有限公司 Continuous production method of acrylamide solution

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61122253A (en) * 1984-11-16 1986-06-10 Nitto Chem Ind Co Ltd Purification of aqueous solution of acrylamide
JP2001078749A (en) * 1999-09-08 2001-03-27 Mitsubishi Rayon Co Ltd Purification of reaction mixture using biocatalyst
JP4959059B2 (en) * 2000-01-17 2012-06-20 三井化学株式会社 Method for purifying amide compounds
JP4668444B2 (en) * 2001-03-27 2011-04-13 ダイヤニトリックス株式会社 A method for producing acrylamide using a microbial catalyst washed with an aqueous acrylic acid solution.
JP2004298155A (en) * 2003-04-01 2004-10-28 Daiyanitorikkusu Kk Method for purifying aqueous solution of amide compound and method for producing the amide compound
KR20080099323A (en) * 2006-02-24 2008-11-12 미쓰이 가가쿠 가부시키가이샤 Process for producing (meth)acrylamide
JP4652426B2 (en) * 2008-03-10 2011-03-16 三井化学株式会社 Method for producing heat-treated bacterial cell solution containing nitrile hydratase

Also Published As

Publication number Publication date
JPWO2011007725A1 (en) 2012-12-27
WO2011007725A1 (en) 2011-01-20
JP5430659B2 (en) 2014-03-05

Similar Documents

Publication Publication Date Title
CA2879538C (en) Production of highly purified sodium hyaluronate (hana) with controlled molecular weight
JP4970276B2 (en) Method for producing amide compound
JP2008535490A (en) Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation
KR101289148B1 (en) Acrylamide methacrylamide production method
US7749739B2 (en) Process for producing amide compound using microbial catalyst
JP5659489B2 (en) Method for stabilizing acrylamide aqueous solution
TW201107479A (en) Fabrication method of microbial cell treated material
FR2835531A1 (en) PROCESS FOR THE PRODUCTION OF AMIDES IN THE PRESENCE OF MICROBIOLOGICAL NITRILE HYDRATASE AND NEW MICROORGANISM
JP4668444B2 (en) A method for producing acrylamide using a microbial catalyst washed with an aqueous acrylic acid solution.
DE60133691T2 (en) PROCESS FOR CLEANING AMIDES
JPWO2004090148A1 (en) Method for producing high-quality acrylamide polymer using enzyme
EP2006390B1 (en) Process for production of acrylamide
JP2008247979A (en) Method for producing high-quality (meth)acrylamide polymer
JP5925355B2 (en) Method for stabilizing amide compound having unsaturated bond
JP5295622B2 (en) Method for producing target compound using bacterial cell catalyst
JP2019089727A (en) Method of purifying amide compound
JP7020614B2 (en) A method for producing a cell-treated product containing a nitrile hydratase and a method for producing an amide compound.
JP2008138089A (en) Manufacturing method of (meth)acrylamide polymer of high quality
JP4709186B2 (en) Method for producing amide compound using microbial catalyst
WO2007116824A1 (en) Method of producing acrylamide
JP2007295933A (en) Method for producing amide compound by using microorganism catalyst
JP2012217351A (en) Method of producing compound using microbial catalyst